QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer for all outstanding QIAGEN shares at €46.50 per share. Learn more ➡ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen
Qiagen
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer (CEO). More on Wikipedia
-
QIAGEN
@QIAGEN
-
QIAGEN
@QIAGEN
QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer for all outstanding QIAGEN shares at €46.50 per share.
Learn more ➡ corporate.qiagen.com/English/newsroom/press-releases/pres… -
QIAGEN
@QIAGEN
Our QIAstat-Dx bloodstream infection portfolio is now complete in the U.S. with FDA clearance of the QIAstat-Dx BCID GN Plus AMR Panel. Learn more ➡ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen -
QIAGEN
@QIAGEN
We are excited to announce the launch of QIAmini, a compact automated sample preparation system designed for research laboratories processing smaller sample batches. Learn more ➡ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen -
QIAGEN
@QIAGEN
We are excited to announce the commercial launch of QIAsymphony Connect, our new IVD-compliant platform for automated clinical nucleic acid extraction. Learn more ➡ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen -
QIAGEN
@QIAGEN
QIAGEN has appointed Jonathan M. Pratt as our new Chief Executive Officer, effective September 1, 2026. Learn more ➡️ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen -
QIAGEN
@QIAGEN
We are excited to announce that we have received U.S. FDA clearance for the QIAstat-Dx BCID GPF Plus AMR Panel, our first panel for bloodstream infections in the U.S. Learn more ➡ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen -
QIAGEN
@QIAGEN
We exceed our Q2 2026 outlook, our growth pillars deliver solid sales growth, and we reaffirm our full-year outlook. Learn more ➡ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgenPost not available here, view on X
QIAGEN
@QIAGEN
✅ H1 2026 operating cash of $301 million remains at a strong level compared with H1 2025
QIAGEN
@QIAGEN
✅ Full-year 2026 outlook reaffirmed for net sales growth of about 1-2% CER and adjusted diluted EPS of at least $2.43 CER
-
QIAGEN
@QIAGEN
The shift from qPCR to digital PCR is accelerating, and gene expression is where it gets really interesting. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qgen #qia -
QIAGEN
@QIAGEN
We are stepping up to support infectious disease research and surveillance efforts for the Bundibugyo ebolavirus outbreak. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen -
QIAGEN
@QIAGEN
We are thrilled to announce the global launch of QIA Agent, our new AI-powered digital assistant, now live on qiagen.com. Try it now 👉 www.qiagen.com/ch?qia-agent-conversation-id=new&intcmp=CM…
#qia #qgen -
QIAGEN
@QIAGEN
We are excited to announce a new collaboration with @NVIDIAHealth to advance AI-driven drug discovery. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qgen #qia #nvda -
QIAGEN
@QIAGEN
We are excited to announce two major innovations coming to QuantiFERON latent TB testing: a fully automated Sample to Insight workflow and an AI-enabled risk stratification tool, both targeted for late 2027. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen -
QIAGEN
@QIAGEN
We are expanding into bloodstream infection syndromic testing with the launch of the QIAstat-Dx BCID GPF Plus AMR Panel, now CE-IVDR certified. Learn more ➡️ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen -
QIAGEN
@QIAGEN
Good news for faster diagnostics. @QIAGEN has received U.S. FDA clearance for the use of its QIAstat-Dx® Gastrointestinal Panels on the fully automated QIAstat-Dx Rise syndromic testing system. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Another quarter of top execution against our targets. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen
QIAGEN
@QIAGEN
◾ Q4 2025: Net sales of $540 million (+4% at actual rates, +1% at constant exchange rates (CER)); diluted EPS of $0.49 and adjusted diluted EPS of $0.62
QIAGEN
@QIAGEN
➡ Net sales growth of 1% CER ahead of outlook for steady results vs. Q4 2024, adjusted diluted EPS of $0.62 CER ahead of outlook of about $0.60 CER
Post not available here, view on X
QIAGEN
@QIAGEN
➡ Adjusted operating income margin at 29.5%, rises 80 basis points from 2024 despite tariffs and currency headwinds
QIAGEN
@QIAGEN
◾ 2026 outlook: Net sales growth of at least 5% CER with growth pillars expected to contribute about $1.64 billion CER (~+9% CER) and adj. diluted EPS of at least $2.50 CER
-
QIAGEN
@QIAGEN
Our latest CDP scores show steady progress on sustainability as we begin 2026:
🌍 Climate Change: A–
💧 Water Security: B–
Progress doesn’t happen overnight. It’s built step by step. Learn more about our ESG ratings and sustainability initiatives 👉 corporate.qiagen.com/English/newsroom/press-releases/pres… -
QIAGEN
@QIAGEN
We are excited to welcome Mark Stevenson as a new member of our Supervisory Board as of January 23, 2026. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen -
QIAGEN
@QIAGEN
🎯 We’re excited to announce our 2026 priorities, setting a clear course to drive growth across five strategic pillars as we progress toward our 2028 ambitions. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
What moves us forward each year is a shared purpose: advancing science and improving healthcare so people can benefit from better answers and better outcomes. As we wrap up another year, we want to thank you for being part of our journey. Wishing you a warm holiday season.
-
QIAGEN
@QIAGEN
Imagine how a simple blood draw can show what is happening inside a tumor. This is how Guardant Health uses liquid biopsy to understand tumor behavior in real time. But how does this approach work in practice? ➡️ www.qiagen.com/us/customer-stories/gene-expression-meets-…
-
QIAGEN
@QIAGEN
As people cross borders and more patients receive immune-suppressing treatments, hidden TB infections can reactivate, even in places where cases seem low. That’s why reliable TB testing matters. Learn more ➡️ www.qiagen.com/de-ch/customer-stories/tuberculosis-in-the…
-
QIAGEN
@QIAGEN
Ever wondered what sustainability looks like in numbers? We did too, so we did the math, and the results are in. See for yourself in our Sustainability Statement 2024 ➡️ s28.q4cdn.com/125951340/files/doc_financials/2024/ar/2024…
#qgen #qia -
QIAGEN
@QIAGEN
We are excited to unveil the QIAsymphony Connect, the next generation of automated nucleic acid purification platform and to showcase new precision oncology innovations at AMP 2025. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We are excited to announce our plans to acquire Parse Biosciences, a fast-growing innovator in single-cell sample preparation whose technologies are used in more than 3,000 labs across over 40 countries. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen -
QIAGEN
@QIAGEN
We exceeded our outlook for Q3 2025, raised our FY 2025 adjusted EPS target, announced the Parse acquisition and $500 million share repurchase to be completed in early January 2026. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgenPost not available here, view on X
QIAGEN
@QIAGEN
◾ $500 million synthetic share repurchase to be completed in early January 2026 as QIAGEN delivers ahead of plan to return $1 billion to shareholders by end-2028
QIAGEN
@QIAGEN
◾ Full-year 2025 outlook reaffirmed for net sales growth of about 4-5% CER (about 5-6% CER core sales) and raises adj. diluted EPS target to about $2.38 CER
-
QIAGEN
@QIAGEN
We are excited to announce the milestone of the 4,000th QIAcube Connect placement, reaffirming our leadership in automated sample processing. Learn more ➡ corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We are humbled to announce that our full QIAstat-Dx portfolio has secured CE-IVDR certification. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Join the Global #tb Summit 2025 for the latest tuberculosis (TB) research, inspiring stories and powerful connections. Register now for free ➡ www.qiagen.com/ch/knowledge-and-support/knowledge-hub/eve…
• Learn from 35+ experts
• Network with thousands of #tuberculosis advocates
• Earn CPD and CME creditsThis media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
✨ Exciting news: QIAstat-Dx Rise has received U.S. clearance! This higher-throughput system brings rapid syndromic testing to more patients and more labs. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Smart pediatricians stay updated on TB infection testing at every stage. Are you prepared for infancy through college? 📖Get the trusted guide now, read our ebook. 👉 www.qiagen.com/de-ch/tb-testing/risk-groups/ebook
#pediatrics #tbtesting #qft #quantiferon -
QIAGEN
@QIAGEN
Exciting news! We exceeded our Q2 2025 outlook with solid growth and improved profitability. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
Post not available here, view on X
QIAGEN
@QIAGEN
➡ Diagnostic solutions sales +11% CER, driven by QIAstat-Dx (+41% CER) and QuantiFERON (+11% CER) and companion diagnostic partnerships
QIAGEN
@QIAGEN
◾ 2025 net sales outlook increased to +4-5% CER (prior about +4% CER) and +5-6% CER core sales (prior about +5% CER); adj. diluted EPS outlook reaffirmed for about $2.35 CER
-
QIAGEN
@QIAGEN
Think all healthy guts look the same? Not even close.
In Southeast Asia, AMILI is building a gut microbiome bank just for the region, with help from QIAGEN’s EZ2 PowerFecal Pro Kit, to make healthcare more local and more personal.
See how 👉 www.qiagen.com/customer-stories/inside-the-worlds-largest… -
QIAGEN
@QIAGEN
We’re growing our NGS portfolio with the new QIAseq xHYB Long Read Panels, making it easier to explore even the most complex genomic regions using native long-read sequencing. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🎉 We are humbled to share that QIAGEN has again been recognized as one of the Best Places to Work for Disability Inclusion in both the United States and Germany.
👏 Thank you to our QIAGENers who foster a culture of inclusion, accessibility, and respect every day. -
QIAGEN
@QIAGEN
🔎 It could be hiding in plain sight.
Have you checked your QIAGEN red and blue boxes lately? A cool collectible might be hiding in plain sight.
🎯 If you spot it, scan the QR code and unlock next-level precision for your research.
#digitalpcr #dpcr -
QIAGEN
@QIAGEN
We are excited to announce a new strategic global partnership with GENCURIX, a leading diagnostics company specializing in oncology, to jointly develop and commercialize digital PCR-based oncology diagnostic products. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We’re partnering with @Incyte to develop a companion diagnostic panel for patients with mutant CALR-expressing myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We’re expanding our oncology diagnostics portfolio with two new strategic partnerships focused on advancing minimal residual disease (MRD) testing in clinical trials — supporting pharma co-development for future companion diagnostics. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We are excited to announce that @GenooxTeam , a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests, has joined @QIAGEN. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Exciting news! We delivered solid Q1 2025 results, exceeding our outlook, and will seek shareholder approval to initiate a dividend and launch a new $500 million repurchase. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qiagen #qia #qgenPost not available here, view on X
QIAGEN
@QIAGEN
◾ Proposal at Annual General Meeting to introduce a dividend as expansion of capital allocation strategy, also seek authorization for a new $500 million share repurchase
QIAGEN
@QIAGEN
◾ Stephen H. Rusckowski proposed to become new Chairman of Supervisory Board as Lawrence A. Rosen chooses to step down from Board after upcoming AGM
QIAGEN
@QIAGEN
◾ 2025 outlook reaffirmed for about 4% CER sales growth (about +5% CER core sales growth); recently increased adj. diluted EPS outlook reaffirmed for about $2.35 CER
-
QIAGEN
@QIAGEN
🎉 Exciting news! We are expanding our digital PCR portfolio to address growing quality control demands in cell and gene therapy manufacturing. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Exciting news! We are coming to AACR 2025 with new products and partnership updates to advance cancer genomic profiling.
Read more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres… -
QIAGEN
@QIAGEN
From reduced plastic and smarter packaging to temperature-stable kits that cut down on cold shipping, we’re rethinking how science can be more #sustainable.
Discover how we're going greener 👉 www.qiagen.com/de-ch/sustainability/environment/go-greene… -
QIAGEN
@QIAGEN
We are advancing automation in sample preparation with three new instruments that support evolving lab needs – from high-throughput screening to decentralized research. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Unlock your potential with QIAGEN! We've got the latest tech and tools for your success, but we need the real MVPs to complete the QIApack. Tag yourself or someone who's making a difference in the lab! #scienceheroes #qiagen #lablife
-
QIAGEN
@QIAGEN
Doctors can’t treat what they can’t see – that's why diagnostics matter. We want to help you transform medicine with molecular tech. Come chat with us at ESCMID booth C40 to learn how we can work together.
Explore our full #escmid program now. 👉www.qiagen.com/de-ch/applications/syndromic-testing/event…This media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
We’re humbled to introduce the QIAprep& Plasmodium Kit – a new solution that simplifies #malaria detection by combining sample preparation and #qpcr in one streamlined workflow. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Q-rious is back to brighten your March. Register now for the live stream of "NGS and dPCR: The biomarker dream team" 👉 qrious.qiagen.com
Step into the sunshine of this episode and light your path to finding promising biomarkers using #ngs and validate them with #dpcr. -
QIAGEN
@QIAGEN
The fight against #tuberculosis needs all of us.
On March 24, QIAGEN is bringing together global #tb experts, healthcare leaders and advocates to discuss TB management.
Be part of the movement. Join us for expert insights, inspiring stories and powerful discussions. 👇 -
QIAGEN
@QIAGEN
Women at QIAGEN are everywhere — creating in labs, perfecting in production, strategizing in offices, collaborating in the field and keeping it all running behind the scenes.
Science moves forward because of them. Happy International Women’s Day!
#iwd2025 #internationalwomensday -
QIAGEN
@QIAGEN
🚀 Another milestone for QIAstat-Dx in the U.S.! We have received FDA clearance for the QIAstat-Dx Gastrointestinal Panel 2 Mini B. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
😨 50% of you chose the wrong option! A few days ago, we asked: Which infectious disease is the world’s leading killer? The answer: #tb (#tuberculosis).
✅ Learn more about the World TB Day event by @QIAGEN on March 24 and register now 👉 www.qiagen.com/de-ch/applications/tb-management/events/wo… -
QIAGEN
@QIAGEN
🤔What’s the leading infectious disease killer?
Cast your vote below and find out the answer here 👉
www.qiagen.com/applications/tb-management/events/world-tb… -
QIAGEN
@QIAGEN
Precision meets breadth. Combine NGS with dPCR for biomarker monitoring that’s both broad and efficient. From validation to longitudinal tracking, this synergy could transform your molecular testing. Start your journey here 👉 www.qiagen.com/de-ch/applications/digital-pcr-mdx/biomark…
-
QIAGEN
@QIAGEN
🌍 Exciting news from Down Under! We are expanding our bioinformatics footprint with a brand-new data center in Melbourne! Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Sepsis is a leading cause of hospital deaths. Physician & researcher Tim Sweeney saw this firsthand - patients waiting hours for test results while sepsis silently progressed.
But what if we could detect the risk earlier by analyzing the immune system’s response? 👇 -
QIAGEN
@QIAGEN
Exciting news! We delivered solid Q4 2024 growth ahead of our outlook. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgenPost not available here, view on X
QIAGEN
@QIAGEN
➡ Free cash flow rises 63% to $506 million.
QIAGEN
@QIAGEN
◾ 2025 outlook for about 4% CER sales growth (about +5% CER core sales growth) and adj. diluted EPS of at least $2.28 CER; targeting adj. operating income margin improvement of at least 150 basis points.
-
QIAGEN
@QIAGEN
We are proud that our therascreen KRAS RGQ PCR Kit has been approved by the FDA as a companion diagnostic for KRAZATI® in combination with cetuximab for colorectal cancer.
This approval allows healthcare professionals to identify colorectal cancer patients with the KRAS mutation. -
QIAGEN
@QIAGEN
🎉 We’re excited to announce U.S. clearance for the QIAstat-Dx Gastrointestinal Panel 2 Mini B&V, tailored to provide rapid answers for outpatient diagnosis of gastrointestinal conditions. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
If you want to make your lab work more productive and cost-efficient, we have good news for you! QIAcuity dPCR now supports high-order multiplexing capabilities without requiring instrument hardware changes, enabling deeper insights from biological samples. Learn more 👇
-
QIAGEN
@QIAGEN
🎉 We are proud to support the British National Health Service (@NHS) and @genomicsengland with our Clinical Knowledge Base to power a first-of-its-kind whole-genome sequencing study for newborns. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We're proud to announce that QIAGEN has once again achieved a perfect 💯 in the Human Rights Campaign Foundation’s 2025 Corporate Equality Index (CEI)!
This recognition underscores our unwavering commitment to fostering an inclusive workplace where LGBTQ+ equality thrives. -
QIAGEN
@QIAGEN
We are excited to announce the launch of our Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🎉 Exciting news! Our EZ2 Connect has reached a significant milestone with over 1,000 placements worldwide, contributing to a global installed base of more than 5,500 EZ series instruments! Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
👋 ¡Hola, Esplugues de Llobregat! We are excited to announce a major milestone for QIAstat-Dx: the development of a new state-of-the-art site in Esplugues de Llobregat, Barcelona to drive growth in infectious disease and precision medicine testing.
👉 corporate.qiagen.com/English/newsroom/press-releases/pres… -
QIAGEN
@QIAGEN
✨ We are excited to announce our collaboration with McGill University to advance microbiome research and generate evidence-based knowledge for medicine and public health. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We exceeded our outlook and delivered a solid performance in Q3 2024. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgenPost not available here, view on X
QIAGEN
@QIAGEN
➡ Free cash flow up 73% to $364 million in first nine months of 2024 vs. same 2023 period.
QIAGEN
@QIAGEN
◾ FY 2024 net sales outlook reaffirmed for at least $1.985 billion CER on solid core business trends; adj. diluted EPS outlook increased to at least $2.19 CER.
-
QIAGEN
@QIAGEN
🎉 We are thrilled to announce @US_FDA clearance for the QIAstat-Dx Respiratory Panel Mini, enhancing precision in outpatient respiratory treatment. This is the third QIAstat-Dx test approved for clinical use in 2024. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🚀 We’re excited to announce the launch of PGXI, a new knowledgebase designed to advance insights into pharmacogenomics, the study of how an individual’s genetic makeup influences their response to medications. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🤔 Did you know the fungal pathogen Batrachochytrium dendrobatidis is driving a mass amphibian extinction? Could engineering their microbiomes help protect them? Learn more 👉 www.qiagen.com/de-ch/customer-stories/protecting-amphibia…
-
QIAGEN
@QIAGEN
✨ We’re excited to announce the expansion of our automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplantation, reinforcing our leadership in non-invasive liquid biopsy applications. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Congratulations to David Baker from the @UW, who has been honored with this prestigious award for his groundbreaking discovery in computational protein design. At QIAGEN, we are proud to stand beside and support the world's brightest minds
Photo credit: @UWGameScience -
QIAGEN
@QIAGEN
Imagine a world where precision medicine is part of the clinical pathway for most patients. In the Talking Precision Medicine podcast, Thierry Bernard shares his vision for the future of precision medicine – and explains how QIAGEN is helping to make it become a reality.
-
QIAGEN
@QIAGEN
Congratulations to Victor Ambros from the @UMassChan, and Gary Ruvkun from @harvardmed for receiving the 2024 #nobel Prize in #physiology or #medicine for their outstanding research on the discovery of #microrna and its role in post-transcriptional gene regulation.
#nobelprize -
QIAGEN
@QIAGEN
📌 The educational and clinical Global #tb Summit 2024 is almost here! Haven't registered yet? Secure your spot at the event that's shaping the future of TB management! 👉 www.qiagen.com/de-ch/applications/tb-management/events/tb…
#tuberculosis -
QIAGEN
@QIAGEN
✨ We’re thrilled to announce the launch of our QIAcuityDx digital PCR system, which expands our digital PCR portfolio into clinical testing in oncology. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
✨ Exciting news! Our QIAstat-Dx syndromic testing systems and panels have received CE-marking under the new EU IVDR framework! Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🙌 We asked what excites you the most about the Global TB Summit 2024, and you said Latest #tb education.
✅ At the 2024 summit, learn from 35+ TB experts, hear inspiring patient stories and earn CPD and CME credits.
✅ Register now: www.qiagen.com/de-ch/applications/tb-management/events/tb… -
QIAGEN
@QIAGEN
Being diagnosed with blood cancer can change your life in an instant. To increase survivorship rates, early diagnosis and treatment are more important than ever. But how can we achieve this? Learn more 👉 www.qiagen.com/de-ch/clp/blood-cancer-awareness-month
#fightbloodcancer #bloodcancer #cancer -
QIAGEN
@QIAGEN
We are excited to announce our partnership with @BodeTechnology, the largest private U.S. forensics laboratory company, to further advance the use of our GEDmatch PRO forensic genetic genealogy database. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We are excited to announce an important milestone! We launched over 100 new assays for our digital PCR (#dpcr) platform QIAcuity via GeneGlobe, exceeding the 2024 goal. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
✨ We’re excited to announce that @QIAGEN has been recognized as one of "America's Most Admired Workplaces 2025" by @Newsweek and Plant-A! Learn more 👉 rankings.newsweek.com/americas-most-admired-workplaces-2025
-
QIAGEN
@QIAGEN
🎉 We're thrilled to announce the expansion of our partnership with Bio-Manguinhos/Fiocruz, the leading provider of vaccines and diagnostics to the Brazilian Ministry of Health, to enhance malaria and dengue detection across Brazil. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
As we gear up for the Global #tb Summit 2024, we’re excited to reunite with #tuberculosis (TB) experts this year. What are you most excited about? Let us know below and learn more here 👉 www.qiagen.com/de-ch/applications/tb-management/events/tb…
-
QIAGEN
@QIAGEN
🎉 We are excited to announce our collaboration with @EliLillyandCo to support the development of a QIAstat-Dx IVD panel that identifies patients at risk for developing #alzheimer’s disease. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
📢 We’re excited to announce our THREE-module course that lasts a total of THREE hours. It’s available until November 30.
🤔 And what rhymes with THREE? Free. Because it’s also free. And comes with an official CPD certificate. It’ll be a real THREE-ller. Enroll now 👇 -
QIAGEN
@QIAGEN
✨ We are excited to announce the expansion of our syndromic testing platform, QIAstat-Dx, into precision medicine with @AstraZeneca, developing companion diagnostics beyond #oncology for future therapies for chronic diseases. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
At @QIAGEN, AI isn't just a buzzword - it's a core part of our operations. Michael Flossdorf, Head of Data Science and AI, shares how AI is driving efficiency, enhancing customer service, and shaping the future of the company. Learn more 👉 www.qiagen.com/de-ch/about-us/our-views/ai-is-here-to-stay
-
QIAGEN
@QIAGEN
🤔 Why are respiratory infections so tricky? Similar symptoms, different causes, & seasonal peaks make them a challenge.
✅ QIAstat-Dx tests for multiple pathogens in just an hour, offering precise, timely care.
Solve the puzzle for your patients! 👉 www.qiagen.com/de-ch/applications/syndromic-testing/syndr… -
QIAGEN
@QIAGEN
🤔 What would you like to learn about in a dPCR course?
✅ If you’re looking for a free course to cover all these #dpcr topics, then don’t miss our “Learn and Grow: A Certified Digital PCR Course” 👉 event.on24.com/eventRegistration/EventLobbyServlet?target… -
QIAGEN
@QIAGEN
🤩 We are excited to launch our new miRNA Resource Center! It has everything you need for miRNA research. Learn more 👉 www.qiagen.com/de-ch/applications/molecular-biology-resea…
🔬 miRNA workflow solutions
🎥 Webinars
🛠️ Tools & custom assay services
📚 miRNA resources & more -
QIAGEN
@QIAGEN
❓ Ever wonder how easy it would be if you could combine DNA and RNA NGS workflows? 📢 The new QIAseq Multimodal DNA/RNA Library Kit helps you achieve just that. The kit enables DNA & RNA library prep in under 6 hours from a single sample. Learn more 👉 www.qiagen.com/ch/products/discovery-and-translational-re…
-
QIAGEN
@QIAGEN
Join the Global #tb Summit 2024 for the latest #tuberculosis (TB) research, inspiring stories and powerful connections. Register now for free 👉 www.qiagen.com/applications/tb-management/events/tb-summit
✅ Learn from 35+ experts
✅ Network with thousands of TB advocates
✅ Earn CPD and CME credits -
QIAGEN
@QIAGEN
🎉It's #rnaday! Celebrate with us by testing your #mirna knowledge and win a special gift! 🎁
Learn more: gopro.qiagen.com/mirna-quiz
Try out a sample question ⬇
In which organism was the regulatory function of miRNA first discovered? -
QIAGEN
@QIAGEN
We exceeded our outlook and delivered a solid performance in Q2 2024. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ FY 2024 outlook updated after solid H1 2024 results ahead of outlook.
QIAGEN
@QIAGEN
➡ Updated net sales outlook of at least $1.985 billion CER reflects solid core business trends and NeuMoDx decision.
QIAGEN
@QIAGEN
➡ Adj. diluted EPS outlook increased to at least $2.16 CER.
-
QIAGEN
@QIAGEN
If you have ever asked yourself how to be more #sustainable in the lab, then we have an answer for you: Reduce, Reuse, and Recycle! Watch this video and join Nathan Susnik, our senior content manager, as he shows you how, with one tiny snap of the fingers, you can change so much!
-
QIAGEN
@QIAGEN
The human body has trillions of microbes aiding digestion, boosting immunity, and influencing metabolism. So why not the same for plants and soil? Learn how manipulating plant microbiomes can help crop security 👉 www.qiagen.com/de-ch/customer-stories/manipulating-plant-…
-
QIAGEN
@QIAGEN
QIAGEN LLC has been recognized as a Best Place to Work for Disability Inclusion by the Disability Equality Index with a top score! This Index is the leading tool for disability, inclusion, and equality. Thanks to all QIAGENers for fostering an inclusive and welcoming environment!
-
QIAGEN
@QIAGEN
We are thrilled to partner with the Snow Molecular Anthropology Lab at the @umontana to enhance the identification of human remains of Indigenous people and African Americans. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
In this week’s interview with @BiotechTVHQ, our CEO Thierry Bernard describes latest sample, assay, and bioinformatics technologies that are powering life sciences and molecular diagnostics.
Learn how these innovations are powering the future of research and healthcare 👇 -
QIAGEN
@QIAGEN
Up to 13 million people in the US carry latent TB infection – and children are at increased risk for progression from infection to contagious active TB disease.
At what age is TB testing with modern TB blood tests recommended by the @AmerAcadPeds for children at risk for TB? -
QIAGEN
@QIAGEN
At @QIAGEN, we believe that our commitment to diversity and inclusion drives our success and innovation. By creating an environment where everyone feels accepted and valued, we empower our team to reach their highest potential.
#pridemonth #lgbtq #qiaversity #diversity -
QIAGEN
@QIAGEN
🤔 Do you wish you had a smile as nice as a Neanderthal’s? Celebrate World Microbiome Day by discovering the surprisingly great teeth of these extinct people, and what they might teach us about the modern oral microbiome 👉 www.qiagen.com/customer-stories/could-the-ancient-oral-mi…
-
QIAGEN
@QIAGEN
From combating TB in Alaska to bringing new hope to lung cancer patients, our customers are heroes making a tangible impact on millions of lives. Read these stories and more in our Insights Magazine. 👉 online.flippingbook.com/view/131282404/
-
QIAGEN
@QIAGEN
✅ We're excited to share our progress on #esg and our commitment to sustainable growth in 2023.
🤔 Curious about our #sustainability achievements in 2023? Download the full report here 👉 s28.q4cdn.com/125951340/files/doc_financials/2024/sr/QIAG… -
QIAGEN
@QIAGEN
On Monday, we rang the closing bell at the @NYSE to mark our targets for 2028! Our leadership team presented the company’s mid-term goals to the financial community and our strategy until 2028. Learn more 👉 capitalmarketsday2024.qiagen.com/home/default.aspx
#qia #qgenThis media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
🤩 A new version of QIAGEN Clinical Insight Interpret (QCI Interpret), is now available! It features significant performance and scalability enhancements for high-throughput NGS labs transitioning to larger test panels and higher volumes. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We are thrilled to launch new QIAcuity dPCR assays for microbial applications to target a wide range of pathogens responsible for tropical diseases, sexually transmitted infections, and urinary tract infections. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
At @QIAGEN, our colors are in our DNA! We celebrate the diversity and inclusivity of our team. This Pride Month, we honor the voices of our LGBTQ+ colleagues, like Sam Hey, highlighting the integral roles we all play in the Pride initiative.
#pridemonth #lgbtq #diversity -
QIAGEN
@QIAGEN
Did you know tuberculosis has reclaimed the title of the world’s deadliest infectious disease from COVID-19? Our CEO, Thierry Bernard, stresses the urgent need for global coordination and investment in TB control measures to eradicate the disease and prevent future outbreaks. 👇
-
QIAGEN
@QIAGEN
We are proud to announce the launch of the QIAstat-Dx Gastrointestinal Panel 2 in the U.S. after its recent clearance for clinical use by the U.S. Food and Drug Administration (@US_FDA). Read more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We are thrilled to announce that, in partnership with @myriadgenetics, we are developing a Homologous Recombination Deficiency test that helps doctors decide the best treatment for cancer patients faster and more accurately. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#healthcare -
QIAGEN
@QIAGEN
✨ Exciting news! We are launching our QIAseq Multimodal DNA/RNA Lib Kit, which enables streamlined DNA and RNA library preparation for next-generation sequencing from a single sample. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Cancer survivors are living longer than ever, but what are the costs of treatment side effects on quality of life? Hannah Wardill at the University of Adelaide is looking into the human gut microbiome for answers. 👉 www.qiagen.com/customer-stories/gut-microbiomes-as-a-canc…
-
QIAGEN
@QIAGEN
In a recent interview with Investment Reports, our CEO Thierry Bernard discusses why molecular testing has never been more crucial than it is today. And why he sees QIAGEN better positioned than ever to address the industry's shifting trends.
-
QIAGEN
@QIAGEN
It’s official: Our clinical decision support platform QIAGEN Clinical Insight Interpret is now IVDR certified in Europe. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🎉 Exciting news: The @US_FDA has cleared our QIAstat-Dx Respiratory Panel Plus syndromic test for clinical use. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
In collaboration with the @FBI, we are set to boost forensics by developing a digital PCR assay for our QIAcuity systems that improves DNA quantification in human samples. Read more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We are thrilled to announce the launch of our cloud-based software QCI Secondary Analysis that enhances bioinformatics workflows for #oncology and inherited disease applications. Learn more 👉corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Say goodbye to complicated #digitalpcr workflows, and hello to simplicity. Learn more 👉 www.qiagen.com/de-ch/applications/digital-pcr-mdx
-
QIAGEN
@QIAGEN
We exceeded our outlook for Q1 2024 and are on track to achieve our full-year 2024 guidance. Read more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgen
QIAGEN
@QIAGEN
◾ Q1 2024: Net sales of $459 million (-5% actual rates, -5% constant exchange rates, CER); diluted EPS of $0.36 and adjusted diluted EPS of $0.46.
Post not available here, view on X
QIAGEN
@QIAGEN
➡ Strong operating cash flow rises 85% to $133 million vs. Q1 2023.
QIAGEN
@QIAGEN
◾ 2024 outlook reaffirmed for at least $2.0 billion CER net sales and adj. diluted EPS of at least $2.10 CER.
-
QIAGEN
@QIAGEN
🎉 Exciting news: We expand our tuberculosis portfolio with the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for advanced TB research and surveillance. Learn more: tiny.cc/x40vxz
-
QIAGEN
@QIAGEN
🧬 Happy DNA Day! Did you know that when DNA was first discovered, it wasn't called DNA at all? In 1869, Friedrich Miescher isolated a phosphorous-rich substance in white blood cells' nuclei and named it based on its properties. What was DNA originally called by Miescher?
-
QIAGEN
@QIAGEN
Misdiagnosis of #tb can cost lives - unnecessarily. Traditional skin tests lead to misdiagnoses in about 50% of TB cases. Dr. Wendy Thanassi advocates for expanding TB testing beyond #healthcare into other high-risk professions using QuantiFERON to prevent these tragedies.
-
QIAGEN
@QIAGEN
✅ Doctors can’t treat what they can’t see – that's why diagnostics matter. We want to help you transform medicine with molecular tech. Come chat with us at #eccmid booth D20 to learn how we can work together. Explore our full ECCMID program now. 👉 www.qiagen.com/applications/syndromic-testing/events-and-…
-
QIAGEN
@QIAGEN
What type of regulation do diagnostic tests need? Our CEO Thierry Bernard and Scott Whitaker, CEO of @AdvaMedUpdate, argue that the proposed VALID Act meets the dynamic needs of existing and emerging technology without compromising quality or patient safety. Read more 👇
-
QIAGEN
@QIAGEN
Driven by our commitment to providing answers for victims and preventing further crimes, we are thrilled to launch our sensitive solution for the screening of sexual assault forensic casework samples. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🤩 Exciting news! We're strengthening our portfolio for cancer research, showcasing our latest product launches at the AACR Annual Meeting 2024. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#cancerresearch #aacr #aacr2024 -
QIAGEN
@QIAGEN
🤔 Wondering how to overcome obstacles with FFPE tissues and #liquidbiopsies ? Want to know how to use #ngs and #dpcr in biomarker research?
✅ Join us for Q-rious on April 24 and discover how to simplify the path from biopsies to biomarkers 👉 www.qiagen.com/ch/knowledge-and-support/knowledge-hub/eve… -
QIAGEN
@QIAGEN
💡 We're thrilled to introduce the QIAstat-Dx Analyzer 2.0, now featuring remote access to test results, enhancing connections and efficiency in healthcare. Read more: tiny.cc/upkkxz
-
QIAGEN
@QIAGEN
❓ In São Paulo, an elderly woman's common respiratory symptoms hid an uncommon infection. A young doctor’s testing strategy revealed the surprise. How did they solve the medical riddle? Find out the answer 👉 bit.ly/3TLg62N
-
QIAGEN
@QIAGEN
🤝 Exciting news! We're joining forces with non-profit International Panel Physicians Association 🩺 to boost tuberculosis screening awareness and support global efforts to combat TB. Learn more: tiny.cc/jxwjxz
-
QIAGEN
@QIAGEN
Amidst Finland's endless pines and shimmering lakes, half the population faces a stark reality: Miles separate them from emergency healthcare. Learn how a new medical lifeline is bridging the gap, one test at a time. Learn more 👉 event.on24.com/eventRegistration/unavailable?&eventid=448…
-
QIAGEN
@QIAGEN
🤔 You’re in the field of #moleculartesting? We’ve got exciting news for you. 🧬 A new retrospective study reveals advantages of dPCR for EGFR and KRAS mutation detection in #nsclc patient samples. Learn more 👉 www.qiagen.com/de-ch/applications/oncology/solid-tumor/lu…
-
QIAGEN
@QIAGEN
🎉 We're excited to share our progress on our environmental journey! We've "B"-come better and improved our climate rating from 'B-' to 'B' as assessed by CDP. While we're proud of this advancement, we want to "B" transparent about our unwavering commitment to sustainability 👇
-
QIAGEN
@QIAGEN
Some people think tuberculosis (TB) is a thing of the past, but it's not. It's still here, affecting millions around the world. This World TB Day, we're shining a light on TB to show it's real and spreading the word to help stop it. Let's learn and spread the word together.
-
QIAGEN
@QIAGEN
🎉 We are excited to launch our AI-derived biomedical knowledge base, QIAGEN Biomedical KB-AI, designed to accelerate data-driven drug discovery in the pharma and biotech industries. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#ai #healthcare #biomedical #pharma #biotech -
QIAGEN
@QIAGEN
🐕Dogs have significantly contributed to our lives in various ways, securing a special spot in many of our households. But have you ever wondered how our close relationship with dogs extends beyond companionship to offering vital insights into human health? 👇
-
QIAGEN
@QIAGEN
Great news: our eco-friendlier QIAwave Kits have new ACT labels and our Sample tech lab received our first My Green Lab Platinum certification. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#sustainability -
QIAGEN
@QIAGEN
🤝 Every small, local act can help in our global fight against #tb. This #worldtbday, see the ripple effect of "Local actions, global impact" on our interactive map. 📌 Each pin shares a story of resilience and hope, showing how your contributions fuel the fight against TB. 👇
-
QIAGEN
@QIAGEN
🤔 Struggling with slow, piecemeal diagnostics? Looking for a molecular test that's easy to run and delivers comprehensive answers fast?
✅ See how QIAstat-Dx can transform your lab, and get you from lab bench to bedside in a flash. Learn more 👉 www.qiagen.com/de-ch/applications/syndromic-testing/workflow -
QIAGEN
@QIAGEN
We exceeded our outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qgenPost not available here, view on X
QIAGEN
@QIAGEN
◾ FY 2023: Achieved outlook for at least $1.97 billion CER sales and at least $2.07 CER adj. EPS, +8% CER sales growth in non-COVID portfolio and 27% adj. operating income margin
QIAGEN
@QIAGEN
◾ 2024 outlook for at least $2.0 billion CER net sales; adj. diluted EPS of at least $2.10 CER, reflects adj. operating income margin gains but significant non-operating income pressure
-
QIAGEN
@QIAGEN
We are thrilled to announce that our CLC Genomics Workbench Premium with LightSpeed technology now supports next-generation sequencing (NGS) for somatic cancer secondary analysis. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#healthcare #ngs -
QIAGEN
@QIAGEN
📈 KRAS is the most frequently mutated gene in lung cancer. Mutation testing in KRAS and other genes is vital in lung cancer detection and care. Yet testing is inconsistent. Read a patient and a clinician’s take on biomarker testing and the advances this knowledge can drive.
-
QIAGEN
@QIAGEN
📈 Cervical cancer is the fourth most common cancer across the globe. And it’s a preventable, treatable, detectable and curable disease.
🤔 Do you know what percentage of cervical cancers are caused by persistent HPV infections?
#cervicalcancer #hpv -
QIAGEN
@QIAGEN
🎉 We are excited to announce our partnership with @penn_state University, aimed at shaping research, education, and outreach in microbiomes. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🎉 Exciting news! Our partner @diasoringroup has submitted the LIAISON® LymeDetect® test, jointly developed with @QIAGEN, for @FDA approval, paving the way for early Lyme disease diagnosis. Learn more 👉 int.diasorin.com/sites/default/files/press-releases/PR Ly…
#healthcare -
QIAGEN
@QIAGEN
🤔 Which is the most frequently mutated gene in lung adenocarcinoma?
✅Test your knowledge of lung cancer biomarkers and then listen to our podcast where a clinician and a patient discuss the vital role of biomarker testing in lung cancer 👉www.qiagen.com/clp/advancements-in-nsclc -
QIAGEN
@QIAGEN
🤔 How has GNOMIX's innovative approach transformed genomic research?
👇 Read their story of personalized solutions and advanced technology application in drug trials and genomic research. -
QIAGEN
@QIAGEN
Timothy Rajakumar, Vice President of Medical Sciences at Hummingbird Diagnostics, explains their research for a new method for #lungcancer detection, focusing on monitoring and predicting immunotherapy outcomes at all stages. Learn more 👉 www.qiagen.com/de-ch/customer-stories/new-blood-based-dia…
#cancer -
QIAGEN
@QIAGEN
🎉 Exciting news! We've received FDA clearance for our NeuMoDx CT/NG Assay, for use on both NeuMoDx 96 and 288 versions of our integrated clinical molecular testing system. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#healthcare #sti -
QIAGEN
@QIAGEN
📈 We are stepping up investments in our market-leading QIAGEN Digital Insights (QDI) bioinformatics business to expand our offerings in new geographic regions and market segments. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🌍 We are expanding our presence in the Middle East, supporting public health initiatives in the fight against #tuberculosis, #meningitis, and cervical cancer. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#cervicalcancer -
QIAGEN
@QIAGEN
🙏 As we wrap up this year, we want to take a moment to deeply thank every single one of you.
🌍 Your unwavering commitment to our shared vision of making improvements in life possible has been truly inspiring.
🎇 We wish you a joyful holiday season and a prosperous New Year! -
QIAGEN
@QIAGEN
🌄 Alaska faces a critical health challenge with high Tuberculosis rates, especially in remote and indigenous areas. Discover our efforts in combating TB through awareness, enhanced testing, and supporting the Alaska Native Medical Center.👉 www.qiagen.com/customer-stories/fighting-tb-on-the-last-f…
-
QIAGEN
@QIAGEN
🔎 Did you know antibiotic-resistant infections caused a staggering 1.27 million deaths in 2019? Learn how unified efforts across governments, healthcare, and industries can turn the tide against this silent threat. 👉www.qiagen.com/us/about-us/our-views/antimicrobial-resist…
-
QIAGEN
@QIAGEN
Cases of Mycoplasma pneumoniae infection continue to rise worldwide, especially among children. We’re committed to supporting the global #healthcare community with our QIAstat-Dx Respiratory SARS-CoV-2 Panel. Learn more 👉 www.qiagen.com/de-ch/applications/syndromic-testing/syndr…
-
QIAGEN
@QIAGEN
86% of 39 million people with #hiv in 2022 knew their status. With effective treatment, they can reach undetectable viral loads. Fast HIV testing is key to optimizing treatment. Learn more about our commitment to precise HIV load testing 👉 www.qiagen.com/us/clp/world-aids-day
#worldaidsday -
QIAGEN
@QIAGEN
We're proud to announce that DNA Labs International solved another two significant cold cases with our Kintelligence workflow for forensic genetic genealogy. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🌍 Out of 39M with #hiv in 2022, how many knew their status?
🔬 HIV-load tests are vital for effective treatment and living long, healthy lives. We're helping labs deliver accurate results for better care. Learn more 👉 www.qiagen.com/de-ch/clp/world-aids-day
#aids #hivawareness #worldaidsday -
QIAGEN
@QIAGEN
Treating #hiv is challenging as it hides in immune cells, evading treatment and the immune system. Youry Kim explains her research around reactivating latent HIV and eliminating infected cells. Is a cure on the horizon? Learn more👉 www.qiagen.com/de-ch/customer-stories/unlocking-a-real-cu…
#aids #aidsawareness -
QIAGEN
@QIAGEN
In recognition of #worldprematurityday, we’re diving into the importance of detecting prelabor rupture of membranes (PROM). You’ve seen the facts, but what can be done? The AmniSure ROM Test can be a valuable diagnostic aid. Learn more 👉 www.qiagen.com/clp/amnisure-rom-test
-
QIAGEN
@QIAGEN
👁🗨 Discover our new TissueLyser III bead mill and the RNeasy PowerMax Soil Pro Kit, designed to help researchers manage difficult samples and enable a higher level of efficiency and accuracy. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
In a world of digital wonders, would you believe that #b2bmarketing and sales in high-tech industries are still stuck in the past? Learn more 👉 www.qiagen.com/de-ch/about-us/our-views/b2b-marketing-nee…
Head of our Digital Business Solutions unit, explains why #marketing and #sales require a 21st-century upgrade. -
QIAGEN
@QIAGEN
We are launching new QIAcuity kits and a software update to advance #digitalpcr analysis in crucial sectors like #pharma, #biopharmaresearch, as well as #food and #drug safety. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#healthcare -
QIAGEN
@QIAGEN
Listen to our CEO, Thierry Bernard, as he discusses the power of molecular diagnostics on the latest episode of the @DeviceTalks Podcast. Thierry looks back at the testing situation during the pandemic and shares his perspectives on the future of testing 👉youtu.be/ksPDPb8JjsM
-
QIAGEN
@QIAGEN
Elevate your microbiome research with our newly launched Microbiome WGS SeqSets, offering a comprehensive Sample to Insight workflow designed for maximum efficiency and reproducibility! Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🤝 Looking for a complete workflow from sample to insight? We’ve partnered with @ElemBio to deliver comprehensive #ngs workflows for the AVITI System! Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#healthcare -
QIAGEN
@QIAGEN
We exceeded our outlook for Q3 2023 with 5% CER sales growth in non-COVID products, adjusted EPS of $0.50 CER and reaffirmed our full-year 2023 outlook. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qgen #qiaPost not available here, view on X
QIAGEN
@QIAGEN
➡ 9M 2023: 8% CER sales growth in non-COVID portfolio, led by 88% highly recurring consumables revenues.
QIAGEN
@QIAGEN
◾ Full-year 2023: Outlook reaffirmed for net sales of at least $1.97 billion CER; adj. diluted EPS of at least $2.07 CER.
-
QIAGEN
@QIAGEN
🎉 Exciting news: We are partnering with Myriad Genetics to advance #cancer companion diagnostics! Learn how our collaboration aims to improve patient care and guide treatment decisions. 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🍁 Respiratory season is here, and with it comes the risk of cold and flu. What if you could help your patients get better faster, so they can get back to their lives?
✅ Expanded panel testing for respiratory pathogens has the potential to expedite patient care. -
QIAGEN
@QIAGEN
Identifying the missing in war-torn Ukraine isn't just a search. It's about social complexity, advanced tech, and enduring challenges. The International Commission on Missing Persons sheds light on this journey. Learn more 👉 www.qiagen.com/de-ch/customer-stories/giving-names-to-ukr…
-
QIAGEN
@QIAGEN
✅ We've been tackling #tb together at the Global TB Summit for more than a decade. And guess what? The 2023 edition is just around the corner. If you're not in yet, here's why you need to be!
Don't miss out! Get details and reserve your spot now 👉 www.qiagen.com/de-ch/applications/tb-management/events/tb… -
QIAGEN
@QIAGEN
We are excited to announce the launch of the QuantiFERON-EBV RUO assay to facilitate research of the cell-mediated immune response to the Epstein-Barr virus. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Celebrating the 2023 #nobelprize in #physiology or #medicine awarded to Katalin Karikó & Drew Weissman for their mRNA breakthroughs that enabled COVID-19 vaccines. We are humbled to support such groundbreaking work! Congratulations! 🎉
#nobel -
QIAGEN
@QIAGEN
🔬 We're proud to stand beside and support the United Nations Population Fund in this important mission to eliminate cervical cancer. @QIAGEN is fully committed to the fight against cervical cancer, and together, we're making improvements in life possible! #endcervicalcancer
UNFPA in Eastern Europe & Central Asia
@unfpaeecaro
We're thrilled to have @QIAGEN on board, powering our mission to eliminate cervical cancer. Their contributions in 🔬molecular diagnostics play a pivotal role in early detection and prevention. Together, we're saving lives! #endcervicalcancer
-
QIAGEN
@QIAGEN
✅ We're proud to share our progress on ESG goals. Our efforts again earned us an ISS-ESG „Prime“ rating, positioning us among the industry leaders.
💪 We're committed to making a difference, step by step. Download the full report here 👉 www.qiagen.com/sitecore/service/notfound.aspx -
QIAGEN
@QIAGEN
🤔 Imagine a blood test detecting lung cancer earlier & more accurately. Ever heard of small RNAs (sRNAs)?
🔬 Hummingbird Diagnostics harnessed sRNAs for a groundbreaking test, capturing tumor signals & immune responses. Wondering about their innovative journey? -
QIAGEN
@QIAGEN
📣 Amazing news! We've enhanced our #sustainable QIAwave portfolio with new eco-friendlier nucleic acid extraction kits! Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🎉 The votes for the Global TB Summit poll are in. The topic our TB community is most excited about is: "Detect, test, and treat TB"
✅ Secure your spot at the event that's shaping the future of TB management.
#globaltbsummit #tbevent #tuberculosis -
QIAGEN
@QIAGEN
Vote for the TB topic you're most excited about!
📣 We're gearing up for the Global TB Summit 2023. 🤝 But we can't do it without you. We can't wait to see which topic emerges as the community favorite. 🤔 Learn more 👉 www.qiagen.com/de-ch/tbsummit -
QIAGEN
@QIAGEN
On September 28, get ready to add some color to your #digitalpcr experience. Join our Digital PCR Festival themed “Where colors merge, innovations emerge”.
Our speakers also want to see you there. Scroll right to see why. Register for free 👉 www.qiagen.com/ch/knowledge-and-support/knowledge-hub/eve…
#dpcr -
QIAGEN
@QIAGEN
⏱ Every 30 seconds, someone worldwide is newly diagnosed with blood cancer. Diagnosis is the first challenge.
✅ Join our great lineup of #bloodcancer experts on September 13 and 14, in taking the “I Can” pledge – a decision that improves patients’ lives. -
QIAGEN
@QIAGEN
💭Imagine a disease-modifying drug for Parkinson's! @official_N23 is on the frontlines, using companion diagnostics to pinpoint those who'd benefit most from precision medicines. Could this reshape the fight against neurodegenerative diseases? Learn more👉 www.qiagen.com/de-ch/customer-stories/precision-medicine-…
-
QIAGEN
@QIAGEN
🌎 When there are more than 6.6 million cases of diarrheal disease every year, we need GI diagnostics heroes.
🤝 But even heroes need help. We’re working hard to bring you something new to let you overcome the challenges of identifying GI pathogens in the lab. -
QIAGEN
@QIAGEN
How often is someone newly diagnosed with blood cancer worldwide? As we gear up for our educational Global Oncohematology Summit, streaming live September 13 and 14, test your knowledge about #bloodcancer. Check out the full agenda 👉 www.qiagen.com/de-ch/applications/oncology/blood-cancer/g…
-
QIAGEN
@QIAGEN
🤔 Are you ready to help us build the picture of a TB-free world? Mark your calendars for October 17–19 and get ready to:
✅ Gain insights into TB management
✅ Engage with global TB experts
✅ Network with peers
✅ Earn CPD and CME credits
#globaltbsummit #tuberculosis -
QIAGEN
@QIAGEN
🤔If you could improve just one aspect of your diagnostic lab’s connectivity to make the upcoming respiratory season easier, what would it be?
💻Learn more about how QIAsphere can help your #lab work better during the next #respiratory season and beyond 👉 www.qiagen.com/de-ch/applications/syndromic-testing/produ… -
QIAGEN
@QIAGEN
Did you know about the recent tuberculosis outbreaks in Minnesota, Alabama, Virginia, Arizona, New York, and Canada?
More importantly, how can we put an end to these infectious-disease threats? Marc Destito, our Head of Global Health, has the answer. -
QIAGEN
@QIAGEN
🤔 Do you know how many cases of diarrheal disease were recorded in 2019?
✅ Learn more about the impact of #gastrointestinal illness by taking our quiz – test your knowledge and donate to WaterAid in the process. Find out how 👉 www.qiagen.com/applications/syndromic-testing/syndromic-t… -
QIAGEN
@QIAGEN
See the worldwide endeavors of our customers – from monitoring shifts in the Earth's climate to detecting cancer indicators within blood samples. Explore stories of groundbreaking achievements in healthcare, molecular research and testing – more relevant today than ever before.
-
QIAGEN
@QIAGEN
🙌 We are delighted to have received FDA approval for our therascreen PDGFRA RGQ PCR kit. This kit aids in identifying patients with unresectable or metastatic gastrointestinal stromal tumors positive for the PDGFRA D842V mutation who may be eligible for treatment with AYVAKIT®.
-
QIAGEN
@QIAGEN
Dive into microbiome mysteries with us in Q-rious episode 3. Explore the vast world of molecular giants with microbiome research experts. Register now 👉www.qiagen.com/ch/knowledge-and-support/knowledge-hub/eve…
-
QIAGEN
@QIAGEN
Parasites can play vital roles in maintaining the balance of ecosystems. However, many species are disappearing before they are even documented. The International Parasite Biobank explains the importance of saving parasites and making samples available to researchers globally. 👇
-
QIAGEN
@QIAGEN
Ever wanted to know how we deliver our famous blue boxes on time to customers worldwide? For a story on the complexity of global healthcare logistics, @CNN took a closer look into QIAGEN’s operations and our partnership with @UPS . Watch the full story👉 youtu.be/sKH6pB3fec8
This media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
We delivered ahead of our outlook for the second quarter of 2023 with 9% CER sales growth in our non-COVID product portfolio and updated our 2023 full-year outlook. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qgen #qiaPost not available here, view on X
QIAGEN
@QIAGEN
➡ 9% CER sales growth in non-COVID product portfolio to $457 million, 10% CER sales growth in recurring consumables and related revenues.
QIAGEN
@QIAGEN
◾ Full-year 2023: Outlook revised to net sales of at least $1.97 billion CER due to significant drop in COVID-19 demand and volatility in large-scale customer bulk orders in the OEM business; adj. diluted EPS revised to at least $2.07 CER.
-
QIAGEN
@QIAGEN
🎉 We are proud to receive the customer service award in recognition of our consistently positive after-sales feedback from clinical scientists around the globe via @SelectScience reviews.
-
QIAGEN
@QIAGEN
💻 Gone are the days when you had to rely on old-school manual methods to plan, execute, analyze and access your experiments and results. But now, you face an explosion of digital tools, making it challenging to pick what's right for you.
-
QIAGEN
@QIAGEN
🧬 Get pumped for RNA Day with us and dive into our exciting interactive game. Recall those stop codons and test how fast you can reach the winning score 👉 www.qiagen.com/de-ch/applications/molecular-biology-resea…
#rnaday -
QIAGEN
@QIAGEN
In early 2023, hundreds of dead sea lions washed up on the shores of Peru. In the U.K., researchers have been finding dead foxes and otters with no apparent cause of death.
Find out what happened and how to prevent the potential threat of another human pandemic 👇 -
QIAGEN
@QIAGEN
On July 28th, World Hepatitis Day, we refuse to wait any longer in the battle against hepatitis.
Together, we can accelerate the efforts in eliminating viral hepatitis and prioritize testing and treatment for those in need.
#worldhepday #worldhepatitisday #whd2023 -
QIAGEN
@QIAGEN
🤝 We are happy to announce a new partnership with Niba Labs to offer custom dPCR assay design services for the biopharma industry. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🤔 Feeling cornered trying to identify GI pathogens in the diagnostics lab? Stay tuned – help is coming. Until then, read our second deep dive on culturing and identifying challenging GI pathogens 👉 www.qiagen.com/de-ch/applications/syndromic-testing/syndr…
#infectiousdisease #syndromictesting #gimicrobiology -
QIAGEN
@QIAGEN
🎙 Listen to the latest podcast episode of #hlthforward, where our CEO, Thierry Bernard, discusses the critical role that diagnostics play in the future of our healthcare system. 👉 www.buzzsprout.com/1984227/episodes/13069662
-
QIAGEN
@QIAGEN
Tropical countries often face multi-pathogen infections. Dr. Wong from Borneo Medical Center shares how QIAstat-Dx aided in a unique jungle-camp diagnosis. Reduces hospital admissions & improves health👉www.qiagen.com/de-ch/customer-stories/solving-medical-mys…
#healthcare #diagnostics #syndromictesting -
QIAGEN
@QIAGEN
💪 We have the power to transform the fight against TB through early and accurate detection.
⏱ Thanks to LIAISON QuantiFERON-TB Gold Plus, we can now automate and speed up TB testing without compromising accuracy. Learn more 👉 www.qiagen.com/de-ch/applications/tb-management/tb-testin… -
QIAGEN
@QIAGEN
📣 Hold on tight. New GI diagnostics are coming. While you wait for the big announcement, look out for our GI deep dive series and pathogen quiz. Read the first deep dive on E. coli here 👉 www.qiagen.com/de-ch/applications/syndromic-testing/syndr…
-
QIAGEN
@QIAGEN
🤔 How can DNA analysis help wildlife enforcement? The illegal wildlife trade is a major threat to biodiversity. Unfortunately, prosecuting poachers responsible is impossible if confiscated animals cannot be identified. Learn more 👉 www.qiagen.com/de-ch/customer-stories/saving-biodiversity…
-
QIAGEN
@QIAGEN
We are proud to foster a culture of curiosity and growth, celebrating diverse perspectives that drive innovation. Our inclusive environment allows every employee to flourish and contribute uniquely to our collective success.
#lgbtq #diversity #inclusion #pridemonth #lgbtqia -
QIAGEN
@QIAGEN
We are proud to announce FBI approval of our NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS), advancing our commitment to deliver cost-competitive NGS workflows to forensic labs. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🌎 We are delighted to announce that we have been included in the #dax 50 ESG index.
✅ Learn more about our #sustainability initiatives 👉 www.qiagen.com/sustainability
#esg -
QIAGEN
@QIAGEN
We are excited to announce the publication of a new systematic review highlighting the unique clinical value of our industry-leading QuantiFERON-TB Gold Plus test for #tuberculosis. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#endtb #tb -
QIAGEN
@QIAGEN
We strive to create a culture that embraces everyone's individuality and voices. We want everyone to be comfortable bringing their full self to work. This is how we build not just a great workplace but a vibrant and inclusive community.
#lgbtq #diversity #inclusion #pridemonth -
QIAGEN
@QIAGEN
We're proud to announce that the Danish National Genome Center has selected us for variant interpretation in oncology genome sequencing. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Our core strengths are drawn from the #diversity of our team and the spirit of determination that fuels our innovation.
We believe in creating a workplace where everyone feels included. This commitment is not just a part of our culture. It's in our very DNA.
#inclusion #lgbtq -
QIAGEN
@QIAGEN
✅ Our Genomics Services offering makes it possible for scientists to run their research projects and generate top-quality data even when their in-house resources are constrained.
Discover QIAGEN Genomic Services 👉 www.qiagen.com/de-ch/applications/genomic-services -
QIAGEN
@QIAGEN
We believe in the power of open dialogue. Listening to each other fosters growth and continuous improvement. We believe in creating a space where everyone, regardless of their identity, feels heard, respected, and valued.
#lgbtq #diversity #inclusion #pridemonth #lgbtqia -
QIAGEN
@QIAGEN
Emily recently celebrated her 18th birthday, a milestone that seemed impossible when she was diagnosed with cancer at age 5. After treatments failed twice, a groundbreaking therapy was found.
Join her journey and discover how @EWhiteheadFdn is supporting other cancer patients. -
QIAGEN
@QIAGEN
🤔 Q-rious about how to make your #laboratory more sustainable? Join us June 13 for expertise & entertainment, tricks & tips and more. Register now and retweet. Register now 👉 www.qiagen.com/ch/knowledge-and-support/knowledge-hub/eve…
#phdchat #research -
QIAGEN
@QIAGEN
✅ Discover the key component behind major scientific advancements, now available as individual products – QIAGEN high-quality enzymes. Learn more 👉 www.qiagen.com/gb/product-categories/discovery-and-transl…
💪 Together, we are one step closer to making improvements in life possible.
#enzymes -
QIAGEN
@QIAGEN
🤔 Want to make your #laboratory more #sustainable and reduce electricity use? Looking for more tips?
✅ Download our infographic with the top 3 freezer tips (and many more) for saving energy while staying cool. 👉 img.go.qiagen.com/Web/Qiagen/{160679aa-779a-4545-a28e-d21…
#phdlife #research -
QIAGEN
@QIAGEN
How do you identify an ancient piece of bone, a single piece of fur, or a crushed insect leg? Claire Griffin, a sequencing expert, has seen it all and continues to innovate ways to decipher even the most unusual samples.
Learn more 👉 www.qiagen.com/customer-stories/identifying-bizarre-sampl… -
QIAGEN
@QIAGEN
We exceeded our outlook for the first quarter of 2023 with 12% CER sales growth in our non-COVID product portfolio. Learn more 👉corporate.qiagen.com/English/newsroom/press-releases/pres…
#qgen #qiaPost not available here, view on X
QIAGEN
@QIAGEN
➡ 12% CER sales growth in non-COVID product portfolio to $434 million, while COVID product sales decline 76% to $52 million.
QIAGEN
@QIAGEN
◾ Full-year 2023 outlook reaffirmed for at least $2.05 billion net sales CER, led by double-digit CER growth in non-COVID products; adj. diluted EPS of at least $2.10 CER.
-
QIAGEN
@QIAGEN
Despite the unbearable conditions and overwhelming challenges in #ukraine, Dr. Olha Konstantynovska, a #tb physician, has chosen to stay and fight for her patients.
Learn more about her incredible efforts in diagnosing and treating TB patients. 👉 www.qiagen.com/de-ch/customer-stories/the-hidden-tb-epide… -
QIAGEN
@QIAGEN
🌏 QIAstat-Dx goes to Japan! We are thrilled to announce the launch of our #molecular testing device in Japan, adding to more than 100 countries worldwide where QIAstat-Dx solutions are available. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#respiratory #pcr -
QIAGEN
@QIAGEN
We are excited to welcome Steve Rusckowski, the former Chairman, President, and CEO of Quest Diagnostics, who has joined as a new member of our Supervisory Board and will stand for election at the Annual General Meeting in June 2023. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🌎 Did you know it’s #earthday2023 today? Check out the blog to see how you can reduce waste and save energy. Learn more 👉 www.qiagen.com/us/sustainability/environment/more-sustain…
#investinourplanet #sustainability #earthday -
QIAGEN
@QIAGEN
🎉 Exciting news! We are hosting the Global Solid Tumor Summit, a two-day hybrid event on April 25-26, where we'll address current challenges in #cancer treatment and diagnostics. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🌟 We are showcasing cutting-edge cancer research tech at #aacr2023! Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#cancerresearch #dpcr #liquidbiopsy #cancer #digitalpcr -
QIAGEN
@QIAGEN
Solid tumors account for the vast majority of cancers diagnosed. But do you know how are #dpcr and #ngs driving advances in solid tumor #biomarker testing?
Join oncology experts at the Global Solid Tumor Summit for the latest research and insights 👉 globalsolidtumorsummit.qiagen.com -
QIAGEN
@QIAGEN
🤔 What can a single bone tell us about a person? Read the incredible story of Nici Vance and discover how forensic scientists are using #dna analysis to solve challenging cold cases. Learn more 👉 www.qiagen.com/customer-stories/how-can-you-identify-a-pe…
#hid -
QIAGEN
@QIAGEN
🙌 We are proud to announce that our #qiaxcel Connect instrument has won the prestigious Red Dot award from what is one of the world’s most important #design competitions. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🙌 We are proud to announce that we have received approval for our net-zero carbon emissions target from the Science Based Targets initiative (SBTi). Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#pharmaceutical #lifesciences #biotechnology #sustainability -
QIAGEN
@QIAGEN
Our CEO Thierry BERNARD has been elected Chair of the Board of Directors of AdvaMedDx, the industry organization that represents more than 75 manufacturers of innovative in vitro diagnostic (IVD) tests and technologies in the U.S. and abroad. Learn more 👉 www.advamed.org/industry-updates/news/qiagen-ceo-thierry-…
-
QIAGEN
@QIAGEN
🚀 We are live!
🙌 Global TB experts are ready to discuss how to fight TB. Join us 👉 www.qiagen.com/de-ch/applications/tb-management/events/wo… -
QIAGEN
@QIAGEN
Thierry participated in this week’s session of the Bipartisan Commission on Biodefense to share his views on how digital PCR and wastewater surveillance can help the nation to better prepare for the next pandemic and other future biological threats.
Bipartisan Commission on Biodefense
@Biodefensecomm
"We have partnered early with public health agencies to deploy new technologies for wastewater testing, including digital PCR." - Thierry Bernard, CEO and Managing Director, @QIAGEN
biodefensecommission.org/events/informing-blueprint-2-0-p… -
QIAGEN
@QIAGEN
Why is #digitalpcr taking over #qpcr? On March 29, we unveil more about that in our brand-new infotainment show Q-rious. During this 60-minute episode, our creative and quirky presenters explain the advantages and uses of "d before q in PCR." Register here 👇
-
QIAGEN
@QIAGEN
🌍 At QIAGEN, we empower our employees to make a difference in the world.
🤝 We provide a dynamic and inclusive work environment where QIAGENers have opportunities to develop their skills and advance their careers.
✅Join us and be part of our team👉 www.qiagen.com/de-ch/careers -
QIAGEN
@QIAGEN
🤝 Exciting news! @QIAGEN is partnering with @Servier to develop a #companiondiagnostic for acute myeloid leukemia (#aml) therapy drug. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🎉 Happy International Women's Day! We at QIAGEN believe that creating a more inclusive workplace starts with cultural change.
🙌 Get to know some of our amazing female employees who are helping drive this change 👇
#womeninleadership #womenempowerment #iwd2023 #embraceequity -
QIAGEN
@QIAGEN
✅ #workflow integrity unlocks the full potential of liquid biopsies. We're delivering the industry’s most-trusted, specific, and complete workflows for top-quality results that make improvements in life possible.
Learn more about the exciting potential of #liquidbiopsies 👇 -
QIAGEN
@QIAGEN
🤝 We are happy to announce the start of our new #qiaseq Platform Partnership program and the first partnership with @SOPHiAGENETICS. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#sophiagenetics #ngs #precisiondiagnostics -
QIAGEN
@QIAGEN
We've been working hard to raise awareness about #tb. But it's not enough.
That's why we’re using #worldtbday to draw the world's attention to one of the deadliest diseases in human history.
Join us for an all-day learning event on TB 👉 www.qiagen.com/de-ch/applications/tb-management/events/wo…
#wefighttb -
QIAGEN
@QIAGEN
Peter Hesse, Vice President Head of Genomics at QIAGEN, discusses the value of NGS technology in clinical, industrial and commercial applications and the strengths of QIAGEN’s platform-agnostic NGS solutions.
Read the full article ▶️ cell-culture-europe.lifesciencesreview.com/cxoinsight/unl… -
QIAGEN
@QIAGEN
🙌 Thank you! With your help, we donated $3000 to @WWF . By taking part in our #sustainability challenges, you not only helped raise awareness, but you also supported the WWF to preserve precious wilderness and reduce human environmental impact.
Learn more 👇 -
QIAGEN
@QIAGEN
We exceeded our outlook for the fourth quarter and full-year 2022 with 14% CER sales growth in FY 2022 from non-COVID product groups. Full press release ➡️ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qgen #qiaPost not available here, view on X
QIAGEN
@QIAGEN
◾ Operating cash flow rises 12% to $715 million; free cash flow up 30% to $586 million.
QIAGEN
@QIAGEN
◾ 2023 outlook initiated for at least $2.05 billion net sales CER, including double-digit CER growth in non-COVID products vs. 2022; adj. diluted EPS of at least $2.10 CER.
-
QIAGEN
@QIAGEN
🤔 What do you see as the next game-changer in #cancer research?
✅ We asked, "Why is cancer #research important to you?" QIAGENers and cancer researchers told us why 👉 www.qiagen.com/applications/cancer-research/world-cancer-day
#cancerresearch #worldcancerday #worldcancerday2023 -
QIAGEN
@QIAGEN
🌎 We’re proud to be included once again in the 2023 @Bloomberg #genderequality Index for driving accountability through data transparency.
✅ Our gender balance is 49% women to 51% men. In 2022, the proportion of women in management reached 35%, up from 28% in 2018.
#dataforgood -
QIAGEN
@QIAGEN
Head of Global #health, Marc Destito spent more time on planes than he did on the ground on his last visit to Africa. But why does he keep going back? Learn more 👉 www.qiagen.com/de-ch/careers/meet-the-qiageners/the-sky-i…
-
QIAGEN
@QIAGEN
🤝 We accelerated our digital transformation through the powerful adoption of the @Azure cloud services of our strategic partner @Microsoft. Learn more 👉 www.microsoft.com/en/customers/story/1564668822794808069-…
-
QIAGEN
@QIAGEN
Now you can accelerate the speed and lower your costs for whole exome sequencing (WES) and whole genome sequencing (WGS) analysis. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🤔 Have you heard of ACT labels that score products on their environmental impact?
🌎 Take part in the poll now to donate $5 to @WWF.
✅Learn more about ACT labels 👉 www.qiagen.com/de-ch/sustainability/environment/more-sust…
✅Learn more about the T&C 👉 eur02.safelinks.protection.outlook.com?url=https://img.go…
#sustainability #sustainable -
QIAGEN
@QIAGEN
We're proud to launch our EZ2 Connect #mdx for use in #diagnostic #laboratories making the IVD platform for automated sample processing available for widescale use. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
The team at DNA Labs International identifies assailants who need to pay for their crimes and stopped from committing new ones. Most of their cases are current, so time is of the essence. But new technology has also made it possible to re-open cases long gone cold. Learn more 👇
-
QIAGEN
@QIAGEN
🤝 We are proud to welcome Verogen, a global leader in next-generation sequencing (NGS) and forensic genealogy, into the QIAGEN family. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We are delighted to announce our strategic partnership with population genomics leader Helix to advance next-generation sequencing (NGS) companion diagnostics for hereditary diseases. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We wish you all happy holidays and a great start to the New Year!
Thank you for your continued support in bringing our vision to life: Making improvements in life possible.
Here's to a successful 2023 – with all sorts of new (molecular) insights just waiting to be unlocked. -
QIAGEN
@QIAGEN
The prevalence of long COVID has taught us that there’s still so much we don’t understand about viral infections. Learn how one doctor in Rome is helping to expand our understanding by balancing his medical practice with epidemiological research. 👉 www.qiagen.com/us/customer-stories/where-surfing-and-synd…
-
QIAGEN
@QIAGEN
We are delighted to have received FDA approval for our therascreen KRAS kit as a companion diagnostic test to Mirati Therapeutic’s KRAZATI for non-small cell lung cancer (NSCLC). Read more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
We're to be part of @NYSE's 99th Annual Tree Lighting campaign, which honors our ongoing support for Ukrainian refugees. We have been working with @TRATWA to collect essential items and donate them to those who most need them. Let there be peace in 2023.
#nyseglobalgiving $QGEN -
QIAGEN
@QIAGEN
🤔 Need cell line ‘omics data to optimize your preclinical studies? Read our new blog post to discover an easy way to select and characterize cell lines using a new database of authenticated and reliable cell line ‘omics data. 👉 digitalinsights.qiagen.com/news/blog/discovery/cell-line-…
-
QIAGEN
@QIAGEN
❓What percentage of people living with HIV currently know they have the virus?
✅Learn more about World #aids Day and our progress in the fight against HIV. 👉 www.qiagen.com/clp/world-aids-day-2022
#aidsawareness #aids_day22 -
QIAGEN
@QIAGEN
🌎 Styrofoam packaging, used in cold chain shipping globally, has a high environmental footprint – polystyrene degrades slowly and can leach chemicals into the environment. But we’ve found a surprising and #sustainable alternative. Learn more 👉 www.qiagen.com/de-ch/sustainability/environment/straw-a-n…
-
QIAGEN
@QIAGEN
We are proud to launch the monkeypox test for our NeuMoDx platform to fight the global outbreak by boosting research and surveillance. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🎊 QIAGEN wins an honorable mention for helping save 6,732 metric tons of CO2. Find out more about the Freezer Challenge & see all the winners 👉 www.labmanager.com/insights/a-global-movement-defining-su…
#sustainability #sustainable -
QIAGEN
@QIAGEN
🤔 Antimicrobial overuse and misuse can drive the development of antimicrobial resistance. What can you do to help? Learn more about antimicrobial resistance and take action 👉 www.qiagen.com/fr-us/applications/syndromic-testing/event…
-
QIAGEN
@QIAGEN
🤔 What actions can the global healthcare community take to help reduce the burden of meningitis?
Read the European Medical Journal interview to learn why rapid diagnostic tools are at the top of the list for improving patient outcomes 👉 www.qiagen.com/applications/syndromic-testing/events-and-… -
QIAGEN
@QIAGEN
📣 We exceeded our outlook for the third quarter of 2022 with 18% CER sales growth in our non-COVID product portfolio and are raising our full-year 2022 outlook. Full press release ➡️ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qgen #qiaPost not available here, view on X
QIAGEN
@QIAGEN
◾ First nine months 2022 operating cash flow up 34% to $591 million, while free cash flow advanced 67% to $504 million on strong business expansion
QIAGEN
@QIAGEN
◾ 2022 sales outlook raised to about $2.25 billion CER, reaffirmed double-digit CER growth in non-COVID products; adj. diluted EPS outlook raised to about $2.40 CER
-
QIAGEN
@QIAGEN
⌚ Get faster and more reliable #biopharma preclinical research results with the new cell line database we launched with ATCC. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
✅ We are making sustainable investments in global health to widen access and increase affordability. Our CFO Roland Sackers shares his views on new pricing models that can stimulate more private sector engagement 👉 www.qiagen.com/de-ch/about-us/our-views/the-virtuous-circ…
-
QIAGEN
@QIAGEN
We hope you're joining us for day 2 of the hybrid Global TB Summit 2022. Plenty more great speakers to come today and you can still sign up to watch today's talks! See you online or in-person in London. 👉 www.qiagen.com/applications/tb-management/events/tb-summit
#tbsummit2022 #tb
QIAGEN
@QIAGEN
The stage is set! We can’t wait to welcome the Chair of the Global TB Summit 2022, Prof. Kon, and our on-site attendees at the Royal College of Physicians in London. #tbsummit2022 #tb #tuberculosis
QIAGEN
@QIAGEN
Prof. Geraint Davies sharing an update on MDR TB treatment regimens at the Global TB Summit 2022. Register now to watch him and other TB experts live in your preferred language. #tbsummit2022 #tb #tuberculosis
QIAGEN
@QIAGEN
Dr. Anna Turkova presenting an update on TB pediatrics. #tbsummit2022 #tb #tuberculosis
QIAGEN
@QIAGEN
Tackling TB Together: Four TB experts discuss four TB clinical cases.#tbsummit2022 #tb #tuberculosis
-
QIAGEN
@QIAGEN
We are waiting for you at the royal college of physicians. Come and join us for day 2 of the Global TB Summit 2022.
#tb #tbsummit2022 #tuberculosis -
QIAGEN
@QIAGEN
Today's the day! We are excited about the Global TB Summit 2022. Presentations start at 09:30 CET for EMEA and APAC and at 10:00 EDT for Americas. You can still register for the talks 👉 www.qiagen.com/applications/tb-management/events/tb-summit
#tbsummit2022 -
QIAGEN
@QIAGEN
🤔 What can practitioners do for their communities? Dr. Danilo Buonsenso believes health is about more than just physical ailments. That’s why he started Surf4 Children, a charity that helps all children experience life to the fullest. Learn more 👉 www.qiagen.com/us/customer-stories/where-surfing-and-synd…
-
QIAGEN
@QIAGEN
Congratulations to our co-founder Prof. Dr. Detlev Riesner.
Merck
@merckgroup
Together with @manager_magazin we inducted Claudia Eckert @TU_Muenchen and Detlev Riesner @HHU_de @QIAGEN into "Hall of Fame of German Research" last night. @angelaschoellig @learnsyslab, and Judith Feucht @TeamJJTueb won the #curiousmind Awards. Congrats!
www.merckgroup.com/en/news/hall-of-fame-21-10-2022.html -
QIAGEN
@QIAGEN
🤔How are you making science more eco-friendly? Share your lab sustainability tips, and we’ll donate US$5 to @WWF. To take part, like this post and:
✅ Share your lab #sustainability tips in the replies
✅ Follow @QIAGEN
Read Terms and Conditions 👉 img.go.qiagen.com/Web/Qiagen/{78ac8c28-ac18-47eb-a4a4-6b5… -
QIAGEN
@QIAGEN
We are deeply invested and committed to the IVDR transition. And we are proud to announce certification for our 𝘪𝘱𝘴𝘰𝘨𝘦𝘯 JAK2 RGQ PCR kit and NeuMoDx platforms. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
Which of these #qiagen #sustainability initiatives do you think is the most effective?
#qiawave -
QIAGEN
@QIAGEN
The #nobelprize in #chemistry was awarded to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless for click and bioorthogonal chemistry. This functional form of chemistry has applications in the treatment of diseases, including targeted cancer treatment. Congratulations!
The Nobel Prize
@NobelPrize
BREAKING NEWS:
The Royal Swedish Academy of Sciences has decided to award the 2022 #nobelprize in Chemistry to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless “for the development of click chemistry and bioorthogonal chemistry.” -
QIAGEN
@QIAGEN
🌎 Despite advances in vaccines and other preventative measures, #meningitis continues to claim lives across the globe.
📝 Take our quiz and join in on our World Meningitis Day activities to raise awareness about this disease.
✅ Get involved 👉 www.qiagen.com/de-ch/applications/syndromic-testing/event… -
QIAGEN
@QIAGEN
Today, the 2022 #nobelprize in #physiology or #medicine has been awarded to Swedish geneticist, Prof. Dr. Svante Pääbo. He has managed the impossible - sequencing the genome of the Neanderthal discovered near our German offices in 1856. Congratulations!
The Nobel Prize
@NobelPrize
BREAKING NEWS:
The 2022 #nobelprize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.” -
QIAGEN
@QIAGEN
✅ Check out the recipients of this year’s Young Scientist Research Grants. Read more 👉 www.qiagen.com/applications/molecular-biology-research/my…
-
QIAGEN
@QIAGEN
Coughing. Fever. Chills. Is it the flu or something else? Find out fast with QIAstat-Dx. Learn how 👉 www.qiagen.com/applications/syndromic-testing/syndromic-t…
#respiratory #qiastat #qiagen -
QIAGEN
@QIAGEN
We might be done with this pandemic. But pandemics are not done with us. How can we stop future viral threats? Learn more 👉 www.qiagen.com/about-us/our-views/pandemics-are-not-done-…
#qiagen -
QIAGEN
@QIAGEN
✨ What invention do you wish you had in the lab? Share your ideas for an invention in the comments. Our first-ever Innovation Forum is one day away. Save your free spot 👉 www.qiagen.com/ch/knowledge-and-support/knowledge-hub/eve…
-
QIAGEN
@QIAGEN
We are announcing new assays for NeuMoDx integrated #pcr system. 👉 Learn more corporate.qiagen.com/English/newsroom/press-releases/pres…
#neumodx #qiagen #monkeypox -
QIAGEN
@QIAGEN
✨ We are excited about our new partnership with Neuron23 to develop a next-generation sequencing companion diagnostic for a novel Parkinson’s disease drug. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qiagen -
QIAGEN
@QIAGEN
🤔 A young girl's chronic anemia turns into a medical puzzle. The answer was in her #dna. Learn more 👉 www.qiagen.com/customer-stories/the-mystery-of-missing-re…
#qiagen -
QIAGEN
@QIAGEN
🎊 Congratulations to the winners of the Second Young Investigator Awards (YIA) for their outstanding scientific work using NGS in HID. Read about their forensic journey 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qiagen #ngs #yia -
QIAGEN
@QIAGEN
🚀 Future-proof your diagnostic lab with QIAstat-Dx connectivity, powered by QIAsphere. Learn more 👉 www.qiagen.com/de-ch/applications/syndromic-testing/produ…
#qiagen #qiastat #qiasphere -
QIAGEN
@QIAGEN
🌎 Global #tb Summit 2022 is approaching fast. Save your free spot 👉 www.qiagen.com/de-ch/applications/tb-management/events/tb… and get ready to:
✅ Join 25+ TB experts online or on-site in London
✅ Learn the latest about TB and earn CPD and CME credits
✅ Hear first-hand accounts of clinical TB cases -
QIAGEN
@QIAGEN
✅ Imagine a future where we can predict outbreaks. Thanks to our WBE solution, this is possible now.
✅ Public health experts are excited about the real potential to detect a whole range of pathogen-related infections before they spread.
Learn More 👉 eur02.safelinks.protection.outlook.com?url=https://www.qi… -
QIAGEN
@QIAGEN
🙌 Proud to see our CEO Thierry Bernard joining the #ceosfordiversity campaign to share our values of diversity and inclusion. Let's all create a working environment where all individuals have equal opportunities.
-
QIAGEN
@QIAGEN
📈 The global monkeypox outbreak is an evolving public health emergency. We’re ready to support your research and surveillance efforts with our new multiplex QIAstat-Dx Viral Vesicular Panel. Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
📣 Do you know that we are expanding our NGS portfolio with new solutions that halve library preparation time for sequencing samples and reduce disposable plastics use by 90%? Learn more👉corporate.qiagen.com/English/newsroom/press-releases/pres…
-
QIAGEN
@QIAGEN
🤔 Wondering how we keep your patients’ confidential information secure?
👉 Learn about the sophisticated security features we’ve built into QIAstat-Dx connectivity, powered by QIAsphere: www.qiagen.com/applications/syndromic-testing/products/qi…
#medicaldevices #medical #clinicalresearch #microbiology -
QIAGEN
@QIAGEN
✅ Explore the future of immunology with Professor Brigitte König, Ph.D. who is on a quest to better understand the use of T-cell therapy and mitochondrial medicine 👉 www.qiagen.com/customer-stories/the-future-of-immunity-is…
-
QIAGEN
@QIAGEN
📣 QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook. Full press release ➡️ corporate.qiagen.com/English/newsroom/press-releases/pres…
#qgen #qiaPost not available here, view on X
QIAGEN
@QIAGEN
◾ H1 2022 operating cash flow +33% to $379 million, free cash flow +63% to $318 million
QIAGEN
@QIAGEN
◾ 2022 net sales outlook raised to at least $2.2 billion CER, reaffirmed double-digit CER growth in non-COVID products; adj. diluted EPS outlook raised to at least $2.30 CER
-
QIAGEN
@QIAGEN
🤔 Multiplex syndromic testing doesn’t have to be complicated. What if running a diagnostic test was as easy as making your morning cup of coffee? ☕
👇 Learn more -
QIAGEN
@QIAGEN
🤔 Do you know that QIAGEN Clinical Insights (QCI) has been used to interpret more than three million patient molecular profiles for hereditary and oncological diseases to date?
👉 Learn more: corporate.qiagen.com/English/newsroom/press-releases/pres… -
QIAGEN
@QIAGEN
🤔 How can we keep pace with the multitude of viruses out there? Learn how Dr. Allison Glass uses the fast results provided by multiplex PCR testing to stay one step ahead of viruses 👉 www.qiagen.com/de-ch/customer-stories/outrunning-viruses-…
#medicaldevices #medical #clinicalresearch #microbiology -
QIAGEN
@QIAGEN
🌎 The only way to scale ESG solutions is to overcome silos and drive active cross-functional and cross-industry teamwork. But is teamwork alone enough? Learn more 👉 www.qiagen.com/us/about-us/our-views/sustainability-takes…
#environment #sustainable #environmental -
QIAGEN
@QIAGEN
📲 Get a birds-eye-view of diagnostic testing across your institution with QIAsphere. Learn how we can help you get set up.
👇 Learn more -
QIAGEN
@QIAGEN
⌚Don’t waste time setting up complicated diagnostic tests. With QIAstat-Dx Rise, you can load and go.
#qiagen #syndromictesting #infectiousdiseases -
QIAGEN
@QIAGEN
🌎 Styrofoam packaging has traditionally been the best solution to ship the products in a cold chain, but it has a high environmental footprint; we have found a sustainable alternative
Learn more 👉 www.qiagen.com/de-ch/sustainability/environment/straw-a-n…
#environment #sustainable #environmental -
QIAGEN
@QIAGEN
We understand the importance of a workplace that allows each person to bring their whole self to work regardless of who they are and who they love.
#pridemonth #lgbtq #qiaversity #diversity #inclusion #equalityact #empowerment -
QIAGEN
@QIAGEN
✅ At the beginning of the COVID-19 pandemic, the first public health lab in Michigan to run PCR tests processed about 90 samples a day.
By the time Omicron hit, it processed 2,700. But how did the they manage keep up with testing needs? Find out more 👇 -
QIAGEN
@QIAGEN
At QIAGEN, we strive to build understanding around sexual orientation, gender identity and expression and promote behaviors fostering belonging for all employees.
#pridemonth #lgbtq #qiaversity #diversity #inclusion #equalityact #empower -
QIAGEN
@QIAGEN
New T-cell testing research using our QuantiFERON SARS-CoV-2 RUO offers insight into the immune response to infection and vaccination of patients with COVID-19. The findings are presented at ASM Microbe 2022, the annual meeting of the American Society for Microbiology.
ASM Newsroom
@ASMnewsroom
Reporting from the press room at #asmicrobe: Commercial T Cell Test Reveals Factors Correlated with Diminished T Cell Responses to #sarscov2 in Clinical Study Subjects asm.org/Press-Releases/2022/June/Commercial-T-Cell-Test-R… @QIAGEN @QIAGENscience
-
QIAGEN
@QIAGEN
QIAGEN is proud to elevate the voices of LGBTQ+ employees and allies through Pride@QIAGEN, an employee led community that aims to raise awareness in the workplace
#pridemonth #lgbtq #diversity #inclusion #equalityact #empower -
QIAGEN
@QIAGEN
Our CEO Thierry Bernard discusses the need for ramping up surveillance testing for COVID-19 – and how to track the monkeypox outbreak.
Yahoo Finance
@YahooFinance
“We need to go into what we call ’surveillance,’” @QIAGEN CEO Thierry Bernard says on COVID. “A non-invasive, very efficient technique is to test wastewater because, from a tiny bit of water, you can detect in advance potential COVID outbreaks for… more than 2 million people.”
This media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
🤔 Did you know that our more sustainable sample prep kits can help you to reduce lab waste? 👇 Here is the answer
-
QIAGEN
@QIAGEN
Inclusivity and diversity are core values at QIAGEN. We are committed to provide an environment where all individuals have equal opportunities.
#pridemonth #lgbtq #qiaversity #diversity #inclusion #equalityact #empower -
QIAGEN reposted
My Green Lab
@My_Green_Lab
At the heart of My Green Lab Sponsor @QIAGEN’s business is a vision for making improvements in life possible. We are proud to have the QIAGEN team help support our mission of creating a global culture of sustainability in science.
-
QIAGEN
@QIAGEN
🤝 @QIAGEN teams up with @my_green_lab to assess the environmental impact of our sample extraction kits. Learn more 👇
-
QIAGEN
@QIAGEN
Think you can’t carry your diagnostic lab in the palm of your hand? Check out the video to see how it’s possible 👇
#medicaldevices #medical #clinicalresearch #microbiology -
QIAGEN reposted
Malcolm Macaulay
@malcolmacaulay
Kudos to @QIAGEN for their sustainable dry ice packaging solutions #hay #sustainability #packaging #dryice
-
QIAGEN reposted
QIAGEN Life Sciences
@QIAGENscience
Young Investigator Annica Gosch talks about her research in #forensic mRNA analysis. She wants to show that details like the time of day biological trace was deposited can be retrieved from transcriptomic data. Is it possible to use mRNA transcripts in this way? Read her blog ⬇️
-
QIAGEN
@QIAGEN
✅ Infectious diseases have met their match with the brand new QIAstat-Dx Rise and our enhanced assay menu.
Learn more 👉 corporate.qiagen.com/English/newsroom/press-releases/pres…
#qia #qiagen #syndromic #qiastat -
QIAGEN
@QIAGEN
✨We are excited that BLIRT SA has joined us. Today we welcome new colleagues from Gdansk to our team who have built an exceptional business around specialty enzymes
🤝Together we will take it to the next level and offer our customers an even broader portfolio to choose from
⬇️ -
QIAGEN reposted
MFT Research and Innovation
@MFT_Research
Manchester’s reputation as a world-class health innovation and life sciences hub has been further solidified through a new strategic partnership between @MFTnhs, @OfficialUoM and @QIAGEN
Find out more👇
mft.nhs.uk/2022/05/10/manchesters-status-as-world-class-h… -
QIAGEN
@QIAGEN
Apply to the Second QIAGEN Young Investigator Awards to get global recognition and support for your work
👉Start now: qiagen.com/yia
#scholarship #researcher #qiagenThis media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
📢#qiagen exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID products and increases full-year outlook. Full press release➡️corporate.qiagen.com/English/newsroom/press-releases/pres…
#qgen #qiaPost not available here, view on X
QIAGEN
@QIAGEN
◾Operating cash flow rises 61% to $207 million, free cash flow increases 116% to $178 million
QIAGEN
@QIAGEN
◾2022 net sales outlook raised to at least $2.12 billion CER, reaffirmed double-digit CER growth in non-COVID products; adj. diluted EPS outlook raised to at least $2.14 CER
-
QIAGEN
@QIAGEN
Watch this video to learn how to extract plasmid DNA in just 20 minutes. #plasmid #dnaday
find out more: www.qiagen.com/de-ch/applications/molecular-biology-resea…This media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
Sustainability means taking complete responsibility for our impact, both positive and negative. We’re working hard to actively mitigate negative impacts, like our CO2 emissions, and drive positive changes, like reducing plastic.
⬇️ Read more about sustainability at QIAGEN -
QIAGEN
@QIAGEN
Knowledge empowers you to improve patient care & outcomes. Visit our Medical Education page for the latest on infectious diseases, reproductive health, transplant virology and immune response. And our Medical Affairs team will be at #eccmid2022, so come say hello.
-
QIAGEN
@QIAGEN
Additional early-warning surveillance is needed to help authorities fight COVID-19. And this is where wastewater testing comes in.
Read More ⬇️ -
QIAGEN reposted
QIAGEN Life Sciences
@QIAGENscience
$15k grants up for grabs. For MSc or PhD students studying #cancer, #microbiome, #microbiology or #sustainability ➡️ www.qiagen.com/applications/molecular-biology-research/my… #ysgrant2022
-
QIAGEN
@QIAGEN
In Dr. Allison Glass' current role as a clinical virologist at Lancet Laboratories, identifying viruses is key to appropriate patient care. And she explains how the QIAstat-Dx has helped speed up various diagnoses.
Read More ⬇️ -
QIAGEN
@QIAGEN
We are proud to announce that our EZ2® Connect has won the Red Dot award, one of the world’s longest running and most important design competitions, for the instrument’s extraordinary design quality and innovation.
-
QIAGEN
@QIAGEN
During the last gasp of 2021, Lancet Laboratories in South Africa made a startling discovery - the new SARS-CoV-2 variant Omicron, which soon gained worldwide attention.
But how did they alert the world about their results in a such short period of time? Here is the answer: -
QIAGEN
@QIAGEN
Today is World TB Day, reminding everyone that most of the 1.5 million TB deaths annually are avoidable. And today, we reached a milestone with 100 million QuantiFERON-TB tests used to screen patients worldwide. Read more at ⬇️
#endtbtoday #worldtbday -
QIAGEN
@QIAGEN
“When I heard the news of the war and the tragedy of the Ukrainian people fleeing their country, I said, we need to act.”
Watch how QIAGENers stand with Ukraine.
#standwithukraineThis media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
When learning about the tragedy at the Polish-Ukraine border, Maggie, the head of our Wroclaw office, traveled to the Ukrainian border to deliver the collection of relief items from QIAGEN employees to refugees from Ukraine who had crossed the border.
#breakthebias -
QIAGEN
@QIAGEN
Our regional sales leader Simona volunteered to help our commercial partner’s employees and refugees in Ukraine.
She stayed in close contact with the partner and helped arrange the accommodation for those who could pass the border with their family members.
#breakthebias -
QIAGEN reposted
Embassy of France in the U.S.
@franceintheus
🇫🇷/🇩🇪 FrenchCEO @Thierry1Bernard : @QIAGEN matches all donations made to two global organizations, and the company’s local teams are creating a pool of volunteers willing to accommodate people from Ukraine.
-
QIAGEN
@QIAGEN
“I want to find out how the warming of the ocean will affect microbial communities and sediments.” – Dr. Stefan Thiele, Microbial Ecologist, Department of Biological Sciences, University of Bergen
"What can Arctic microbes tell us about climate change?" Read more about it ⬇️ -
QIAGEN
@QIAGEN
When it comes to meningitis and encephalitis, minutes matter. To help you get a handle on this, we’ve invited expert Thomas Sundelin Ph.D. to discuss his experiences with multiplex testing for meningitis. Join us on February 21 for his live webinar.
Save your spot 👇 -
QIAGEN
@QIAGEN
Countdown to official launch.
Stay tuned.
#qiagen #sampletoinsight #logo #refresh -
QIAGEN
@QIAGEN
An easy start for cancer research samples – EZ2 Connect for FFPE and liquid biopsies.
Learn how to boost your lab work 👉 www.qiagen.com/us/applications/cancer-research/automation
#cancerresearch #conquercancer -
QIAGEN
@QIAGEN
“The Arctic is two to three fold more prone to climate change due to global warming.” – Dr. Stefan Thiele, Microbial Ecologist, Department of Biological Sciences, University of Bergen
"What can Arctic microbes tell us about climate change?" Read the story ⬇️ -
QIAGEN
@QIAGEN
Solid results in Q4 capped a tremendous year for us. We are very pleased to finish 2021 with strong levels of sales, profitability & cash flow, and that we've been able to also show the strength of our COVID-independent portfolio set to drive future growth. 📈 Read more at ⬇️
-
QIAGEN
@QIAGEN
New milestones further strengthen QuantiFERON’s impact in the global fight against TB: QFT-Plus, our 4th generation TB test, gained approval in China for active TB detection & received new WHO recommendation as alternative IGRA test for diagnosis of TB infection. Read more at ⬇️
-
QIAGEN
@QIAGEN
If you could design an ideal DNA and RNA instrument, what would it be like?
See how easy-to-use EZ2 Connect can boost cancer research.⬇️
#worldcancerday -
QIAGEN
@QIAGEN
“Not many people have had the honor of being here before, and then on the other hand, if something happens, nature wins. You have no chance. ” – Dr. Stefan Thiele, Microbial Ecologist, Department of Biological Sciences, University of Bergen
Read more about it ⬇️ -
QIAGEN
@QIAGEN
QIAGEN U.S. has earned top score of 100 in @HRC Foundation's Corporate Equality Index and has been awarded as one of the Best Places To Work For LGBTQ+ Equality! Learn more about our commitment to fostering a diverse workforce & inclusive workplace at www.qiagen.com/us/sustainability/employees
-
QIAGEN
@QIAGEN
There’s much that remains mysterious about the vast – and melting – Arctic. Microbial ecologist Dr. Stefan Thiele’s role: to reveal the microbial communities living in sea ice, sea water and sediments.
Read the whole story here ⬇️ -
QIAGEN
@QIAGEN
We are proud to be included in the 2022 @Bloomberg Gender-Equality Index, underlining our continuing commitment to #genderequality. And there's also more that makes QIAGEN a great place to work. Learn more at www.qiagen.com/us/careers #bloomberggei #dataforgood
-
QIAGEN
@QIAGEN
Wastewater-based epidemiology has proven to be a vital early-warning surveillance tool for public authorities in the fight against the pandemic. Today, >70% of all U.S. states are using our QIAcuity digital PCR applications for COVID-19 wastewater detection. Find out more ⬇️
-
QIAGEN
@QIAGEN
"There is nothing more constant than change."
Watch the renewal of our brand through the years.
What is coming next? You will find out soon...
#qiagen #sampletoinsight #throwback -
QIAGEN
@QIAGEN
Our new QIAwave products are designed to tackle the persistent problem of laboratory waste faced by scientists worldwide. By using fewer components, recycled plastics & space-saving chemical concentrates, QIAwave kits produce less waste than standard kits. Find out more ⬇
-
QIAGEN
@QIAGEN
COVID-19 has demonstrated the value of testing patients for multiple pathogens from a single sample. By adding new tests and a high-capacity platform to our QIAstat-Dx menu, we significantly expand our syndromic testing options for laboratories and hospitals. Find out more here⬇️
-
QIAGEN
@QIAGEN
Our aim is to make our QIAcuity dPCR plattform the new standard in PCR testing. By collaborating with our new partners Atila BioSystems and Actome GmbH we now add further dPCR applications: non-invasive prenatal testing and protein analysis.
-
QIAGEN
@QIAGEN
QuantiFERON is set to continue to make an impact for people worldwide, not only as the proven gold standard for detecting TB. With a series of new applications, products and automation options we’ll further broaden the reach of our immune response technology. Find out more ⬇️
-
QIAGEN
@QIAGEN
“Sometimes DNA is fragmented and damaged. That’s why we use whole genome amplification to improve that profile…We use a lot of QIAGEN equipment.” – Kelly Elkins, professor of chemistry at Towson University Human Remains Laboratory
Read the whole story ⬇️ -
QIAGEN
@QIAGEN
We want to thank all of you for making improvements in life possible.
Happy holidays and a joyful new year
#qiagen #sampletoinsight -
QIAGEN
@QIAGEN
“The biggest challenges working with historic remains, as well as some other samples, like chewing gum is the low quantity of DNA that you're able to recover.” – Kelly Elkins, professor of chemistry at Towson University Human Remains Laboratory
➡️www.qiagen.com/de-ch/customer-stories/solving-abandoned-c…This media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
Sometimes human remains are unearthed after years hidden underground, for example, by accident at a construction site by developers. At @TowsonU Laboratory, @forensicsprof and Cynthia Zeller use #moleculartesting to investigate historical and cold cases from the colonial era.
-
QIAGEN
@QIAGEN
“At the moment, there are so many things that are affecting coral reefs all around the world.” – Dr. Bry Wilson, marine biologist and bioinformatician at the University of Oxford's Department of Zoology
Follow his story ⬇️ -
QIAGEN
@QIAGEN
Under a new master collaboration agreement with Denovo Biopharma, we will develop a companion diagnostic test for the treatment of diffuse large B-cell lymphoma (DLBCL), one of the most common lymphoid cancers. Find out more ⬇️
-
QIAGEN
@QIAGEN
The emergence of the Omicron variant has necessitated greater scrutiny into SARS-CoV-2 variants.
Explore how whole viral genome sequencing can help build an accurate picture of circulating variants ⬇️
#covid19 #omicron #newmutation -
QIAGEN
@QIAGEN
“Corals are immersed in this incredible microbial soup. It’s an extraordinarily complex ecosystem.” – Dr. Bry Wilson, marine biologist and bioinformatician at the @UniofOxford Department of Zoology
#sampleprep #dnakits #coralreef -
QIAGEN
@QIAGEN
What does the Omicron variant mean for labs and patients? Dr. Allison Glass is a clinical virologist at South Africa’s Lancet Laboratories where her team discovered the new COVID-19 strain. Watch her talk about the impact of the discovery and why continued testing is so important
This media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19
-
QIAGEN
@QIAGEN
This year’s @NYSE Tree Lighting is dedicated to global giving. We’re excited to have our bauble on the tree, highlighting our support for the @TAGTeam_Tweets commited to the fight against social discrimination as well as #hiv, #tuberculosis, and #hcv pandemics.
-
QIAGEN
@QIAGEN
“By using molecular tools, we can actually examine the DNA of these particular organisms and tease apart these kinds of very complex communities.” – Dr. Bry Wilson, marine biologist and bioinformatician at the University of Oxford's Department of Zoology
-
QIAGEN
@QIAGEN
📢QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
Collaboration now provides full range of automation platforms for TB testing options to customers, ranging from small healthcare clinics to larger hospitals and reference laboratories (2/3)
QIAGEN
@QIAGEN
QIAGEN’s QuantiFERON Interferon Gamma Release Assay (IGRA) technology the leading assay for detection of latent TB with high clinical sensitivity (3/3)
-
QIAGEN
@QIAGEN
📢QIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.529. Full press release➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
NeuMoDx 96 and 288 integrated PCR testing systems used in laboratory testing. QIAGEN offers tests worldwide for use on this system for detection of the SARS-CoV-2 virus.
QIAGEN
@QIAGEN
In the U.S., the NeuMoDx Flu A-B/RSV/SARS-CoV-2 VantageAssay is available for use in testing patients with suspect infections.
-
QIAGEN
@QIAGEN
“One of the huge problems that we are facing that people are struggling to receive access to health care.” – Dr. Rosa Herrera, Mycobacteriosis Program Coordinator, Mexicali Institute of Public Health
#tuberculosis #tb -
QIAGEN
@QIAGEN
"We literally have positive test results here in the lab on a daily basis," says Harding, a clinical laboratory scientist and the quality manager for specialty chemicals division."– Kristen Harding, Clinical Laboratory Scientist and the Quality Manager, Mako Medical
-
QIAGEN
@QIAGEN
📢QIAGEN commits to reduce carbon emissions by setting science-based target to reach net zero by 2050. Full press release➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
QIAGEN has committed to do our part in reducing carbon footprint in line with these targets which means by 2030 to reduce Scope 1 and 2 emissions by at least 40% and Scope 3 emissions by at least 10% on the way to reaching net-zero carbon emissions using 2020 as a baseline.
QIAGEN
@QIAGEN
QIAGEN’s ambition includes transitioning facilities to renewable energy, implementing energy-saving measures, minimizing waste in operations, factoring carbon footprints into product development, and working with suppliers and logistical operators to reduce their carbon emissions
-
QIAGEN
@QIAGEN
“I'm very passionate about technologies, because for many years I've been working hands-on in laboratories. With the new technologies, the speed of which you get from pure sample to data is amazing.” – Mogens Kruhøffer, founder and CEO, BioXpedia
-
QIAGEN
@QIAGEN
📢QIAGEN reports strong results for third quarter and first nine months of 2021. Full press release➡️
corporate.qiagen.com/newsroom/press-releases/press-releas…
QIAGEN
@QIAGEN
◾ Q3 2021: Net sales rise 11% (+10% constant exchange rates, CER) to $535 million and adjusted diluted EPS unchanged at $0.58 ($0.58 CER) from Q3 2020, both well above outlook
Post not available here, view on X
QIAGEN
@QIAGEN
◾ 9M 2021: Operating cash flow up 134% to $441 million, free cash flow up 198% to $302 million
QIAGEN
@QIAGEN
◾ Full-year 2021: Outlook upgraded to reflect stronger-than-expected Q3 2021 results, net sales now expected to grow at least 15% CER and adjusted diluted EPS of at least $2.48 CER
-
QIAGEN
@QIAGEN
“I just had shortness of breath and I was always so tired. Later, in an X-ray, I saw a pleural fission almost take over my right lung. I immediately knew I had #tuberculosis.” – Dr. Rosa Herrera, Mycobacteriosis Program Coordinator, Mexicali Institute of Public Health
-
QIAGEN
@QIAGEN
📢QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2
Full press release➡️
corporate.qiagen.com/newsroom/press-releases/press-releas…
QIAGEN
@QIAGEN
With COVID-19 infections now mixing in with common flu and RSV, patients with influenza like illnesses (ILI) present similar symptoms, but need to be treated differently. The CE-marked test for QIAstat-Dx makes it possible to differentiate these illnesses rapidly and accurately.
-
QIAGEN
@QIAGEN
“Since we've introduced LIAISON QuantiFERON-TB Gold Plus, we've been able to provide the results sooner. We've got patients who have had their treatment earlier.” – Michelle Poole, Chief biomedical Scientist, Doncaster Royal Infirmary
#tb #tuberculosis -
QIAGEN
@QIAGEN
After surviving an earthquake, Dr. Rosa Herrera thought the worst was over, but she had contracted #tb after sheltering in a crowded ER with patients and other residents. Now, Herrera is doing all she can to reach out and treat the hardest hit communities.
#tuberculosis -
QIAGEN
@QIAGEN
📢QIAGEN strengthens UK footprint with move to new Manchester facilities
Full press release➡️
corporate.qiagen.com/newsroom/press-releases/press-releas…Post not available here, view on X
QIAGEN
@QIAGEN
◾ City has been base of company’s pioneering role in Precision Medicine for a decade
QIAGEN
@QIAGEN
◾ CityLabs 2.0 facility includes laboratories and workspaces for currently 300 QIAGEN employees
-
QIAGEN
@QIAGEN
We are proud to be part of global #donations programs in Kenya with a donation of testing kits from @AKUHNairobi and the #europeanunion through collaboration with the Ministry of Health at improving systems, economic and social vulnerabilities caused by the #covid-19 pandemic.
-
QIAGEN
@QIAGEN
“Our intention is to not only look at a project itself at the time, but also where it is going and to use the right techniques from the start.” – Mogens Kruhøffer, founder and CEO, BioXpedia
#dpcr #digitalpcr #qiacuity -
QIAGEN
@QIAGEN
📢 QIAGEN launches novel QIAreach QuantiFERON-TB tuberculosis test for high-burden regions
Full press release➡️
corporate.qiagen.com/newsroom/press-releases/press-releas…Post not available here, view on X
QIAGEN
@QIAGEN
◾ TB IGRA testing now accessible in high burden, low resource and decentralized settings
QIAGEN
@QIAGEN
◾ Study data also showcased at the Union World Conference show promising results
-
QIAGEN
@QIAGEN
The field of human #genetics is rapidly evolving at an unprecedented rate. However, with new discoveries come new challenges. Join us at the @GeneticsSociety #ashg21 virtual conference to explore our latest innovations.
-
QIAGEN
@QIAGEN
“You could have tuberculosis and not have any symptoms. That's why people need to get tested for tuberculosis just as they do for any other disease.” – Kristen Harding, Clinical Laboratory Scientist and the Quality Manager, Mako Medical
#tb #quantiferon #tuberculosis -
QIAGEN
@QIAGEN
#spidia4p, a #qiagen coordinated EU-funded Horizon 2020 consortium project to develop new ISO & CEN standards for pre-analytical workflows applied to Personalized Medicine, has won this year´s “Standard + Innovation Project Award” by @Standards4EU.
👉 www.cencenelec.eu/news-events/news/2021/briefnews/2021-10… -
QIAGEN
@QIAGEN
As the @CSICBS series premier went on air last week, we can see they have modernized their lab with #qiagen’s #ez2connect, so their forensic scientists can purify DNA and RNA quickly.
📸 Copyright: @CBS
Get more information👉 outsider.com/american-entertainment/the-new-csi-vegas-lab… -
QIAGEN
@QIAGEN
Clinical researchers are on a quest for breakthroughs in treatment and care. They have to race against the clock to reach milestones to ensure continued funding, and rarely have time to keep track of which technologies are constantly being developed.
#dpcr #digitalpcr #qiacuity -
QIAGEN
@QIAGEN
Many populations are vulnerable to #tuberculosis, but anyone could have unknowingly been exposed. Two committed scientists test different communities in their regions, but they each rely on the same tool to quickly and automatically detect latent #tb.
#quantiferon -
QIAGEN
@QIAGEN
We congratulate David Julius & Ardem Patapoutian to this year’s #nobelprize in Physiology or Medicine. They have been honored “for their discoveries of receptors for temperature and touch”. We are proud to enable groundbreaking discoveries.
The Nobel Prize
@NobelPrize
BREAKING NEWS:
The 2021 #nobelprize in Physiology or Medicine has been awarded jointly to David Julius and Ardem Patapoutian “for their discoveries of receptors for temperature and touch.” -
QIAGEN
@QIAGEN
◾ U.S. government awards $3.4 million to boost production of PCR tests for NeuMoDx 96 and 288 clinical integrated systems
◾ Award follows $600,000 contract to increase output of enzymatic reagents and reagent products -
QIAGEN
@QIAGEN
🔔 12:10 PM
🎤 Prof. Giovanni Battista Migliori, Director of the @WHO Collaborating Centre for TB & Lung Diseases at the Fondazione S. Maugeri and Chair of the Global #tb Network (GTN), Italy
💻 Interaction of COVID-19 and TB
Join now www.qiagen.com/us/clp/tb-summit-2021
#tbsummit2021 -
QIAGEN
@QIAGEN
🔔 11:45 AM
🎤 Dr. Christian Gunneberg, Public Health Specialist, Global Tuberculosis Programme, @WHO
💻 COVID-19 and impact on TB control
Join now www.qiagen.com/us/clp/tb-summit-2021
#tbsummit2021 #tb -
QIAGEN
@QIAGEN
🔔 10:55 AM
🎤 Prof. Adrian Martineau, Clinical Professor of Respiratory Infection and Immunity at Barts and The London School of Medicine and Dentistry (@QMUL)
💻 Toward a microbiological biomarker of latent TB infection
Join now www.qiagen.com/us/clp/tb-summit-2021
#tbsummit2021 #tb -
QIAGEN
@QIAGEN
🔔 10:30 AM
🎤 Dr. Tom Wingfield (@DrTomWingfield), Senior Clinical Lecturer and Honorary Consultant Physician, Liverpool School of Tropical Medicine (@LSTMnews), England
💻 Catastrophic costs
Join now www.qiagen.com/us/clp/tb-summit-2021
#tbsummit2021 #tb -
QIAGEN
@QIAGEN
🔔 10:05 AM
🎤 Prof. Pere-Joan Cardona (@pjcardona14), Professor of Microbiology at the Universitat Autònoma de Barcelona and Chief of the Microbiology Department at the Hospital Universitari Germans Trias I Pujol, Spain
💻 The history of #tb
Join now www.qiagen.com/us/clp/tb-summit-2021 -
QIAGEN
@QIAGEN
The 2021 Global TB Clinical and Educational Summit is going to start in one hour. Register now to attend exciting presentations and interactive panel discussions on TB control and prevention with global #tb experts.
👉 www.qiagen.com/us/clp/tb-summit-2021 #tbsummit2021 -
QIAGEN
@QIAGEN
September is #worldbloodcancerawareness month. Every day, our #oncohematology solutions support advances in diagnosis, clinical #cancerresearch, and bioinformatics insights. Discover how #qiagen can be your partner in oncohematology – for Blood Cancer Awareness month and beyond.
-
QIAGEN
@QIAGEN
On Day 1, @DrTomWingfield will present on "Catastrophic Costs." If you register, you can add individual presentations to your calendar, so you won't miss them. Those who cannot attend can watch the recording later. #tbsummit2021
See you next Tuesday!
Your QIAGEN Event Team -
QIAGEN
@QIAGEN
Proud to be part of the COVID-19 Summit today at the U.N. General Assembly – and to support their commitments made to end the pandemic: 1️⃣ Vaccinating the World, 2️⃣ Saving Lives Now and, 3️⃣ Building Back Better. #preparedness, #accessibility #affordability.
This media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
Signed up for the 2021 Global TB Clinical and Educational Summit yet? It's not too late! #tbsummit2021
-
QIAGEN
@QIAGEN
We are pleased to be included in the new #dax40. Thank you @deutscheboerse.
-
QIAGEN
@QIAGEN
The virtual #qiagen Oncohematology Summit – September 15 and 16 – brings together global #oncohematology experts to discuss their experience and insights in oncohematology diagnostic testing and #bloodcancer clinical research.
Register now 👇 -
QIAGEN
@QIAGEN
Results of a recently published study from @TheLancet support the preferred use of a blood-based IGRA assay like #quantiferon-TB Gold Plus in the U.S. over the traditional TST skin test for latent #tb screening, especially within high-risk populations.
▶️ www.thelancet.com/journals/laninf/article/PIIS1473-3099(2… -
QIAGEN
@QIAGEN
Prof. Onn Min Kon invites you to the 2021 Global #tb Clinical and Educational #summit. Join international #tuberculosis experts between September 28 and October 1.
👉 Free
👉 CPD-accredited
👉 Multilingual
Register now: -
QIAGEN
@QIAGEN
Clinical labs globally are facing ever greater demands on their time and resources. #diagnostic testing shouldn't be complicated. What if running a diagnostic test was as easy as making your morning cup of coffee?
Get more information now 👉
qiastat-dx.com/row/
#qiastatdx -
QIAGEN
@QIAGEN
📢 QIAGEN steigt in den deutschen Leitindex DAX auf. Zur Pressemeldung ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ QIAGEN wird am 20. September 2021 in den DAX aufgenommen, dem Stichtag für Änderungen in der Indexzusammensetzung
QIAGEN
@QIAGEN
◾ QIAGEN verbleibt im TecDAX, der die 30 größten deutschen Unternehmen der Technologiebranche umfasst
-
QIAGEN
@QIAGEN
📢 QIAGEN to Enter the DAX – Germany’s Leading Stock Market Index. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ QIAGEN to join the DAX on September 20, 2021, the effective date for changes in index composition
QIAGEN
@QIAGEN
◾ QIAGEN to remain in TecDAX comprised of the 30 largest German technology sector companies
-
QIAGEN
@QIAGEN
Join international TB experts for the 2021 Global TB Clinical & Educational #summit. This year we will bring together >20 global TB experts to discuss their experience & the latest insights in #tuberculosis control & prevention.
Register now 👇 -
QIAGEN
@QIAGEN
“We want to understand where the regulation of the thousands of complex molecules inside each cancer cell has gone wrong to allow the cancer to grow out of control.” – Dr. Cristin Print, Department of Molecular Medicine & Pathology, University of Auckland
#cancerresearch #qdi -
QIAGEN
@QIAGEN
The #qiagen Oncohematology #summit brings together global experts to discuss their experience & insights in #oncohematology testing & blood cancer clinical research. Join us and gain insights into the future of oncohematology testing.
Save your spot now👇 -
QIAGEN
@QIAGEN
📢 QIAGEN announces the commercialization of the PreAnalytiX PAXgene® Saliva Collector for non-invasive sample collection, storage, and transportation with stabilization of nucleic acid. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ Non-invasive and painless sample collection tool permitting seamless self-collection; initial applications include SARS-CoV-2 research
QIAGEN
@QIAGEN
◾ PreAnalytiX, a BD and QIAGEN joint venture, combines expertise to provide an integrated and standardized workflow solution from saliva sample collection and stabilization to analyte preparation for varied downstream applications and valuable data interpretation
-
QIAGEN
@QIAGEN
We provide regular insights into our customers’ work by having them tell us their stories. Most recently we visited Bry Wilson (@MarineBryology), marine biologist at @UniofOxford to hear about his amazing projects.
-
QIAGEN
@QIAGEN
📢 QIAGEN reaches milestone with its kits used to process more than three billion biological samples to date. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ Company’s NGS assays also hit milestone of one million samples tested since 2015
QIAGEN
@QIAGEN
◾ New kits and instruments will bolster QIAGEN’s position in most crucial area of molecular testing
-
QIAGEN
@QIAGEN
Discover the benefits of ultra-sensitive NGS-based liquid biopsy technology in companion diagnostics. Join our speakers in a free webinar on August 25 to discuss a new and exciting partnership between QIAGEN and Sysmex Inostics. Register now ➡️ register.gotowebinar.com/register/287655748317513483?sour…
-
QIAGEN
@QIAGEN
“Understanding cells in tumors and in other diseases is at the center of all of our work. Without understanding molecular pathways, we'd be absolutely lost.” – Dr. Cristin Print, Department of Molecular Medicine & Pathology, University of Auckland
#cancerresearch #oncology #qdi -
QIAGEN
@QIAGEN
📢 QIAGEN and GT Molecular collaborate to offer a complete SARS-CoV-2 wastewater detection solution based on QIAcuity Digital PCR technology. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ Joint solution launched in August sets new standards, in particular, speed to results in less than two and a half hours
QIAGEN
@QIAGEN
◾ Workflow complies with CDC guidelines for new U.S. wastewater surveillance systems, also designed for use in Canada and other countries worldwide
-
QIAGEN
@QIAGEN
📢 QIAGEN and OncXerna Therapeutics sign licensing and master companion diagnostic agreements. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ Agreements include a non-exclusive license for QIAGEN to the OncXerna Xerna™ TME panel
QIAGEN
@QIAGEN
◾ The agreements broaden QIAGEN’s NGS companion diagnostics capabilities in immuno- oncology clinical development programs
-
QIAGEN
@QIAGEN
SPIDIA4P’s mission to improve global #healthcare by supporting the development and implementation of new CEN and #iso standards for pre-analytical workflows continues! Stay informed about the achievements of the Horizon EU 2020 project and get an overview of relevant standards.
-
QIAGEN
@QIAGEN
📢 QIAGEN Reports Full Results for Q2 and H1 2021. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ Very strong non-COVID product group sales: +52% CER growth in Q2 2021 to $407.6 million, representing 72% of total sales, expect at least 20% CER full-year growth
QIAGEN
@QIAGEN
◾ Excellent cash flow results: H1 2021 operating cash flow rises 89% to $285.0 million and free cash flow up 94% to $195.0 million
QIAGEN
@QIAGEN
◾ Full-year 2021 outlook for at least 12% CER sales growth and at least $2.42 CER adjusted diluted EPS (as announced on July 12)
QIAGEN
@QIAGEN
◾ New $100 million share repurchase program started
-
QIAGEN
@QIAGEN
Today we observe #worldhepatitisday because millions of people around the world are suffering from this disease. Together, we can end viral #hepatitis.
Test your knowledge now with our "World Hepatitis Day 2021 Quiz". -
QIAGEN
@QIAGEN
Did you know? It is now the standard of care in several countries for all pregnant women to be routinely tested for #gbs. Learn more about how your lab can perform rapid multiplex strep testing with NeuMoDx.
#groupbstrepawarenessmonth -
QIAGEN
@QIAGEN
"The DNeasy blood and tissue kit is the one I opt for most often for a wide range of sample types, because it gives us high-quality DNA, even with tricky samples." – Claire Griffin, Senior Sequencing Technician, Natural History Museum, London
#dna #sequencing #sampletoinsight -
QIAGEN
@QIAGEN
You have just finished your master's or bachelor’s degree in Business Administration or other business-focused areas and looking for the next professional challenge? Start your #career as a #trainee Global #finance (m/f/d) with #qiagen.
⬇️Apply now⬇️
www.qiagen.com/us/about-us/careers/jobs/details?nPostingI… -
QIAGEN
@QIAGEN
📢 QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ Updated full-year 2021 outlook due to impact of faster-than-expected uptake of COVID-19 vaccines on test demand: At least 12% CER sales growth and at least $2.42 CER adj. EPS
QIAGEN
@QIAGEN
◾ Commitment to value creation: Announcing new $100 million share repurchase program
-
QIAGEN
@QIAGEN
📢 QIAGEN’s NeuMoDx™ HAdV Quant Assay Secures CE-IVD Certification for Automated Testing to Detect Human Adenovirus Infections. Full press release➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
QIAGEN
@QIAGEN
◾ Important expansion of menu for NeuMoDx™ 96 and 288 Molecular Systems marks the 15th assay with a CE-IVD marking, one of the largest menus available for integrated PCR testing
QIAGEN
@QIAGEN
◾ Driving greater utilization of non-COVID-19 tests in Europe, U.S. and other markets
-
QIAGEN
@QIAGEN
📢 QIAGEN launches the Workflow Configurator to help life science researchers simplify and optimize their laboratory experiments. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
QIAGEN
@QIAGEN
◾ Cloud application marks another milestone for QIAGEN by adding guidance for customers along the entire product portfolio
QIAGEN
@QIAGEN
◾ Application covers seamless portfolio transition from “wet lab” benchtop products through to “dry lab” digital applications
QIAGEN
@QIAGEN
◾ The Workflow Configurator allows customers to quickly find the best workflows tailored to their needs, which they can conveniently order, save or share.
-
QIAGEN
@QIAGEN
“The major challenges with TB in Western countries are above all the social circumstances in which these patients find themselves.” – Dr. Christian Herzmann, Senior Physician and Lung Specialist, Leibnitz Research Center
#tuberculosismanagement #stoptb #endtb -
QIAGEN
@QIAGEN
To control the pandemic, we must first understand and control the #infection. Learn how to improve your research of cell mediated immunity following SARS-CoV-2 vaccination using the QuantiFERON SARS-CoV-2 RUO solution ➡ www.qiagen.com/applications/infectious-disease/coronaviru…
#sarscov2 -
QIAGEN
@QIAGEN
📢 QIAGEN forms strategic alliance with Sysmex Corporation for global cancer companion diagnostics development and commercialization using NGS and Plasma-Safe-SeqS technology. Full press release ➡️
corporate.qiagen.com/newsroom/press-releases/press-releas…
QIAGEN
@QIAGEN
◾ Global strategic alliance to leverage Sysmex’s Plasma-Safe-SeqS technology
◾ QIAGEN will use ultra-sensitive liquid biopsy applications in oncology
QIAGEN
@QIAGEN
◾ Alliance boosts QIAGEN’s co-development of companion diagnostics with drug makers
◾ QIAGEN expects significant benefits for pharma companies and cancer patients worldwide -
QIAGEN
@QIAGEN
📢 QIAGEN Partners with Verogen to Offer Broadest Portfolio for Human Identification, Including Next Generation Sequencing Solutions. Full press release ➡️
corporate.qiagen.com/newsroom/press-releases/press-releas…Post not available here, view on X
QIAGEN
@QIAGEN
◾ Collaboration will provide customers workflow tools and support for highest quality outcomes
QIAGEN
@QIAGEN
◾ Verogen broadens reach of sequencing and analysis products for forensic and human identity samples
-
QIAGEN
@QIAGEN
“Each of our patients has a burden to bear. We have to act with great empathy there.” – Dr. Christian Herzmann, Senior Physician and Lung Specialist, Leibnitz Research Center
#tuberculosismanagement #stoptb #endtb -
QIAGEN
@QIAGEN
Imagine if you could consistently process 192 human or environmental microbiome samples in less than a day, delivering high-quality DNA for PCR and NGS analysis every time. Download our poster from the #worldmicrobeforum gallery to find out more. ➡️ ipostersessions.com
-
QIAGEN
@QIAGEN
@binningsingletons.com on bluesky
@BSingletons
A HUGE thank you to @QIAGEN for their Platinum sponsorship of our program.
Check out their Microbe Masterpiece Contest and Human Microbiome Days!
www.qiagen.com/us/applications/microbiome/microbe-masterp…
event.on24.com/eventRegistration/EventLobbyServlet?target… -
QIAGEN
@QIAGEN
📢 QIAGEN Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Editing Experiments. Full press release➡️corporate.qiagen.com/newsroom/press-releases/press-releas…
QIAGEN
@QIAGEN
◾ QIAprep& CRISPR Kit and Q-Primer Solutions expand QIAGEN portfolio for CRISPR applications
QIAGEN
@QIAGEN
◾ Products are highly sensitive tools for characterizing the impact of CRISPR editing experiments
QIAGEN
@QIAGEN
◾ Solutions combine liquid-based sample preparation with PCR detection and Sanger sequencing
-
QIAGEN
@QIAGEN
“We receive a lot of different types of tissues and materials – teeth, bone, furs, insects - and it’s our job to provide sequencing data for those samples.“ – Claire Griffin, Senior Sequencing Technician, Natural History Museum, London
#dna #sequencing -
QIAGEN
@QIAGEN
Only three days to go!
Dr. Metin Colpan’s sample extraction method revolutionized molecular biology and ultimately healthcare. Now QIAGEN’s co-founder has been nominated for the European #inventoraward 2021. Show your support by casting your vote here➡️popular-prize.epo.org/i/i/metin-colpan-de/ -
QIAGEN
@QIAGEN
Partnering with @RockefellerFdn to help build capabilities that stop the next deadly disease in the first 100 days. Find out how QIAGEN is responding to the pandemic – and is working towards preventing the next one to come. ➡ www.qiagen.com/us/applications/infectious-disease/coronav…
#meetingthismoment -
QIAGEN
@QIAGEN
Of microbes and men – learn about your microbes from world experts, June 8–17
-
QIAGEN
@QIAGEN
Now it's out, our big new project 😃😉 Thanks for sharing!
Tim Mosca (he/him)
@drosophilosophy
i had no idea qiagen made houses. #cityrunner
-
QIAGEN
@QIAGEN
Up to 70% of mammalian cell cultures used to publish work are unknowingly contaminated by bacteria, #viruses, or parasites. Perfectus Biomed has set the course to help researchers & scientists detect #contamination and obtain valid results. Watch their story!
#pcr -
QIAGEN
@QIAGEN
Help protect patients requiring biologics from #tb – join our live webinar on LTBI management. Register now ➡ event.on24.com/eventRegistration/EventLobbyServlet?target…
June 03 | 11 a.m. EDT -
QIAGEN
@QIAGEN
📢 QIAGEN Launches First FDA-approved Tissue Companion Diagnostic to Identify the KRAS G12C Mutation in NSCLC Tumours and Expand Precision Medicine Options in Lung Cancer. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ First tissue-based companion diagnostic to identify the KRAS G12C mutation in NSCLC
QIAGEN
@QIAGEN
◾ Test will be available under QIAGEN’s Day One Lab Readiness program
-
QIAGEN
@QIAGEN
Win the fantastic Gut Check game in our #microbemasterpieces contest.There are 200 games to be won this month by creating an artwork of your favorite microbes. Can you showcase their variety and hidden beauty? Share your vision before May 31 and see the other entries today.
-
QIAGEN
@QIAGEN
📢 QIAGEN Partners With Mirati Therapeutics Inc. to Develop KRAS-G12C Companion Diagnostic for Non-Small Cell Lung Cancer (NSCLC). Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
QIAGEN
@QIAGEN
◾ KRAS mutations in NSCLC reflect a large underserved patient population with an unmet need for innovative treatment options
QIAGEN
@QIAGEN
◾ QIAGEN is developing a tissue-based companion diagnostic in support of adagrasib, Mirati’s investigational selective KRASG12C inhibitor
QIAGEN
@QIAGEN
◾ Program adds to QIAGEN's strong position in KRAS companion diagnostic testing in NSCLC
-
Post not available here, view on XPost not available here, view on X
QIAGEN
@QIAGEN
◾ QIAGEN is developing a tissue-based companion diagnosticin support of adagrasib, Mirati’s investigational selective KRASG12C inhibitor
QIAGEN
@QIAGEN
◾ Program adds to QIAGEN's strong position in KRAS companion diagnostic testing in NSCLC
-
QIAGEN
@QIAGEN
"Half-time" in the popular vote for the #inventoraward 2021. Remember that Dr. Metin Colpan, co-founder of QIAGEN, has been nominated for his lifetime achievement that revolutionized molecular biology. Every vote counts, so please support us in casting your daily vote for him ⬇️
-
QIAGEN
@QIAGEN
Great to see Bettina, our VP Corporate Business Development, being featured as one of 50 women who will shape the future of business. Find out more in the latest issue of the German Magazine STRIVE.
-
QIAGEN
@QIAGEN
“We receive samples often contaminated with rodent DNA, bacteria or fungus. They pose some challenges in getting the correct sequence rather than the contamination.“ – Claire Griffin, Senior Sequencing Technician, Natural History Museum, London
-
QIAGEN
@QIAGEN
“In just three months, with the help of QIAGEN, we built a new molecular biology lab and designed a PCR workflow from sample to insight.” – Dr. Samantha Westgate, CEO and Founder, Perfectus Biomed Group, England
-
QIAGEN
@QIAGEN
📢 QIAGEN Receives U.S. FDA Emergency Use Authorization for Fast and Easy-to-Use Digital Test to Detect SARS-CoV-2 Coronavirus Antibodies. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ Test based on QIAGEN partner Ellume’s proprietary eHub technology and helps ease testing shortfalls by using automation and providing easy-to-read results
QIAGEN
@QIAGEN
◾ eHub digital device can handle eight tests at once, all working independently of each other, can process up to 32 samples per hour, can eventually be used simultaneously with the antigen test
-
Post not available here, view on XPost not available here, view on X
QIAGEN
@QIAGEN
◾ Test based on QIAGEN partner Ellume’s proprietary eHub technology and helps ease testing shortfalls by using automation and providing easy-to-read results
QIAGEN
@QIAGEN
◾ eHub digital device can handle eight tests at once, all working independently of each other, can process up to 32 samples per hour, can eventually be used simultaneously with the antigen test
-
QIAGEN
@QIAGEN
Create #microbemasterpieces to win an exclusive microbiome game. Post your entry by May 31 ➡️ www.qiagen.com/applications/microbiome/microbe-masterpieces
-
QIAGEN
@QIAGEN
A major issue in the management of the COVID-19 pandemic is to have a reliable & early warning of outbreaks. I.A.G.E., a French startup specializing in environmental biological analyses, has used a brilliant technology to confirm cases. Watch their story➡ www.qiagen.com/us/customer-stories/how-oysters-led-to-cov…
-
QIAGEN
@QIAGEN
Dr. Metin Colpan, co-founder, former CEO and Managing Director of QIAGEN, has been nominated as a finalist for the #inventoraward 2021 by @EPOorg in the lifetime achievement category.
Please join us in casting your vote for Dr. Colpan here ➡️ popular-prize.epo.org/i/i/metin-colpan-de/ -
QIAGEN
@QIAGEN
📢 QIAGEN exceeds outlook in first quarter 2021 results, reaffirms sales growth and profitability outlook for full-year 2021. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ Q1 2021 operating cash flow rises over 700% to $128.6 million, free cash flow of $82.3 million
QIAGEN
@QIAGEN
◾ Reaffirming full-year 2021 outlook for ~18-20% CER net sales growth and ~$2.42-2.46 CER adjusted diluted EPS
-
QIAGEN
@QIAGEN
QIAGEN Announces EZ2 Connect Instrument Line for Automated Sample Processing in Research, Forensics and Diagnostics. Full press release➡️corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ Building on the success of EZ1 technology, three versions offer application area tailored value
QIAGEN
@QIAGEN
◾ Integration with QIAsphere digital infrastructure allows for optimized lab productivity
-
QIAGEN
@QIAGEN
"This global monitoring can be proposed for a whole city and for buildings housing people particularly sensitive to this pandemic." - Dr. Olivier Couillerot, business developer and co-founder, I.A.G.E., Montpellier, France
#dpcr #wastewater #qiacuity -
QIAGEN
@QIAGEN
#tuberculosis is one of the top ten causes of death worldwide and every tenth new tuberculosis (TB) case occurs in China. “Treating latent TB in rural China” - get the insights here ➡ www.qiagen.com/us/customer-stories/treating-latent-tb-in-…
#stoptb #endtb #theclockisticking -
QIAGEN
@QIAGEN
📢 QIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect® Assay based on QuantiFERON technology in countries accepting CE Mark for early diagnosis of Lyme Borreliosis. Full press release➡️corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ In clinical studies, the assay showed, within 21 days from the first evidence of infection, a sensitivity of 74% versus that of existing, established methods at 49%, while also demonstrating a high diagnostic specificity of 100%
QIAGEN
@QIAGEN
◾ QIAGEN is responsible for product development and manufacturing, while DiaSorin is responsible for global commercialization of the new solution
-
QIAGEN
@QIAGEN
📢 QIAGEN Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity.
Full press release➡️corporate.qiagen.com/newsroom/press-releases/press-releas…Post not available here, view on X
QIAGEN
@QIAGEN
◾ CE-IVD marking for Europe and other countries worldwide, EUA (Emergency Use Application) submission made in the U.S.
QIAGEN
@QIAGEN
◾ Streamlined workflow cuts costs and plastic usage – offering time to result of about two hours
-
Post not available here, view on XPost not available here, view on X
QIAGEN
@QIAGEN
◾ CE-IVD marking for Europe and other countries worldwide, EUA (Emergency Use Application) submission made in the U.S.
QIAGEN
@QIAGEN
◾ Streamlined workflow cuts costs and plastic usage – offering time to result of about two hours
-
QIAGEN
@QIAGEN
An iconic festival for qPCR loyalists and dPCR enthusiasts alike: Want to be a part of it? Get your free Ticket now ➡️ www.qiagen.com/clp/pcr-festival
#pcr #dpcr #digitalpcr #qiagen #pcrfestival -
QIAGEN
@QIAGEN
“We can correlate the amount of SARS-CoV-2 detected in the #wastewaters to the amount of the population infected.” - Dr. Olivier Couillerot, business developer and co-founder, I.A.G.E., Montpellier, France
-
QIAGEN
@QIAGEN
📢 German language/Germany only - QIAGEN erweitert Test-Portfolio um Antigen-Schnelltests für den deutschen Markt. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
QIAGEN
@QIAGEN
◾ QIAGEN-Initiative ermöglicht Unternehmen, mehr Arbeitskräfte in höherer Frequenz zu testen
◾ Mehrere Millionen Tests pro Monat lieferbar
QIAGEN
@QIAGEN
◾ Zulassung für die Nutzung durch Fachpersonal erteilt
◾ Zulassung für Selbsttestung ohne Fachpersonal für April erwartet -
QIAGEN reposted
SelectScience
@SelectScience
The QIAprep& Viral RNA UM Kit has been nominated for Best New Life Sciences Product 2020! Do you think it deserves to win? Vote today 🔗 uk.surveymonkey.com/survey-closed/?sm=e4onf59qqiJE9b55O6k…
@QIAGEN
#scientistschoiceawards #lifesciences #labequipment #labessentials -
QIAGEN
@QIAGEN
📢 QIAGEN Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Throughput Genomic Surveillance. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
QIAGEN
@QIAGEN
◾ QIAseq DIRECT SARS-CoV-2 Kit halves both library preparation times and plasticware use
◾ Kit supports analysis of over 6,000 samples simultaneously on highest-throughput sequencers
QIAGEN
@QIAGEN
◾ Integrates with QIAGEN Digital Insights cloud solutions to support variant detection and reporting including clade and lineage annotations across sequencing platforms
-
QIAGEN reposted
Oxford Road Manchester
@OxRdMcr
On this #worldhealthday we express our pride and gratitude to all the clinicians, consultants, nurses, ward clerks, porters and more who work at @MFTnhs as well the healthcare industry innovators based here on the Oxford Road Corridor.
-
QIAGEN reposted
RNA-Seq Blog
@RNASeqBlog
We invite you to join our #cancerresearch Lecture on #rna #biomarkerdiscovery with talks and live discussions including: Biomarker exploration by #ngs - Analysis of underlying biological mechanisms in #rnaseq data - Validation by @realtimePCR... - @QIAGEN www.rna-seqblog.com/rapid-biomarker-discovery-rna-seq-qpc…
-
QIAGEN
@QIAGEN
📢QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 Portfolio. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/press-releas…
Post not available here, view on X
QIAGEN
@QIAGEN
◾ The 4-plex test utilizes the high-throughput, automated testing capabilities of the NeuMoDx systems, which has a growing and comprehensive assay menu for respiratory, blood-borne virus, transplant, and reproductive health disease areas
QIAGEN
@QIAGEN
◾ Test adds to QIAGEN’s expanding portfolio of PCR testing solutions for COVID-19 testing
-
QIAGEN reposted
InHealth Ventures
@InHealthVC
Fascinating piece from @aparmarbb in @medcitynews on how the lessons of #covid19 can help arm us for the long-running fight against TB medcitynews.com/2021/03/with-focus-on-the-covid-19-pandem…
-
QIAGEN
@QIAGEN
A festival about PCR. Please join!
QIAGEN Life Sciences
@QIAGENscience
The QIAGEN PCR Festival, April 26–30, 2021, opens its virtual doors and welcomes PCR enthusiasts and experts worldwide. Get ready to immerse yourself in five days of insightful keynotes, the best coaches and an incredible community.
-
QIAGEN reposted
QIAGEN Life Sciences
@QIAGENscience
The QIAGEN PCR Festival, April 26–30, 2021, opens its virtual doors and welcomes PCR enthusiasts and experts worldwide. Get ready to immerse yourself in five days of insightful keynotes, the best coaches and an incredible community.
-
QIAGEN
@QIAGEN
Tuberculosis is the world’s leading infectious disease killer, claiming 1.4 million lives in 2019. Yet TB is preventable and curable. Only by expanding testing for latent TB infection can we finally end the global TB epidemic. #stoptb #endtb #theclockisticking #worldtbday2021
-
QIAGEN
@QIAGEN
"The QuantiFERON test gives us a much more realistic estimate of the number of infections and allows us to narrow down the number of those who need preventive treatment." – Dr. Gao Lei, Chinese Academy of Medical Sciences
#stoptb #endtb #theclockisticking #worldtbday -
QIAGEN
@QIAGEN
COVID-19 has shown the importance of keeping people healthy in the workplace. That’s why we’re joining #ewtb #endtb, #worldtbday ewtb.org @wef, @globalfund, @stopTB, @JNJGlobalHealth
-
QIAGEN
@QIAGEN
We are delighted to be part of a new group of members of Ending Workplace TB and join companies around the world in fighting TB this #worldtbday. Together we can #endtb. Find out more: www.ewtb.org/post/12-new-members-joined-ewtb
-
QIAGEN
@QIAGEN
"This controlled laboratory test requires only one patient visit, is highly specific and sensitive, and a positive result is strongly predictive of a true infection by M. tuberculosis, whether it is latent infection or active disease." – Dr. Elom Emeka
-
QIAGEN
@QIAGEN
“Each person has a right to know his or her TB status before receiving a potentially unnecessary medication.” – Timur Abdullaev, human rights and public health consultant, Uzbekistan
#tuberculosismanagement #stoptb #endtb #theclockisticking -
QIAGEN
@QIAGEN
The clock is ticking. For World TB Day 2021 visit ➡️ www.qiagen.com/applications/tb-management/world-tb-day-2021
- Get insights from customer stories
- Register for expert roundtable discussion on March 23
- Register for live webinar on March 30
#endtb #stoptb #theclockisticking #tuberculosis -
QIAGEN
@QIAGEN
QIAGEN applauds the US efforts to expand testing: Biden administration to invest more than $12 billion to expand COVID-19 testing. www.reuters.com/article/idUSKBN2B92CD
-
QIAGEN
@QIAGEN
"Anyone and everyone in Pakistan is exposed to TB, whether you attend school, step inside a hospital, or simply go shopping. TB spares no one." – Dr. Ahmed Raza Jan, heads of Aziz Medical Center, Islamabad, Pakistan #stoptb #endtb #theclockisticking
-
QIAGEN
@QIAGEN
Join a panel of experts on the theme of TB and COVID. Comment with your questions below. #endtb #stoptb #theclockisticking
-
QIAGEN
@QIAGEN
Comment with your questions below and join a panel of experts on the theme of #tuberculosis and #covid. #stoptb #endtb #theclockisticking
-
QIAGEN
@QIAGEN
How are different countries combatting #tuberculosis? #stoptb #endtb #the ClockIsTicking
This media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
Happy International Women´s Day. Diverse teams are critical to our ability to make improvements in ALL lives possible. #choosetochallenge
-
QIAGEN
@QIAGEN
📢 QIAGEN launches QIAsphere cloud-based connectivity solution to enhance QIAstat-Dx capabilities in digital diagnostics. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/2021/2021030…
QIAGEN
@QIAGEN
• Major step towards bringing customer service to critical and syndromic testing
QIAGEN
@QIAGEN
• QIAsphere mobile App enables real-time and remote test monitoring from anywhere, and will be available for additional QIAGEN instruments in coming months
QIAGEN
@QIAGEN
• QIAstat-Dx customers can benefit from 24/7 remote service to enhance testing continuity
-
QIAGEN
@QIAGEN
📢 QIAGEN launches QIAcube Connect MDx platform for automated sample processing in diagnostic labs. Full press release ➡️ corporate.qiagen.com/newsroom/press-releases/2021/2021030…
Post not available here, view on X
QIAGEN
@QIAGEN
• Device allows labs to use in-vitro diagnostics (IVD) and more than 140 other QIAGEN standard protocols
QIAGEN
@QIAGEN
• Platform builds on success of over 9,800 installed QIAcube and QIAcube Connect instruments
-
QIAGEN
@QIAGEN
What are the best practices and workflows for #wastewater monitoring of SARS-CoV-2? A new series of events begins with a roundtable of international experts on March 9. Register now!
-
QIAGEN
@QIAGEN
„Die Wertschätzung der Biotechnologie ist durch die Coronakrise nachhaltig gestiegen. Das sollte unserer Branche weiteren Rückenwind geben.“ – Roland Sackers, CFO von QIAGEN www.handelsblatt.com/unternehmen/industrie/cfo-des-monats…
@BIODeutschland -
QIAGEN
@QIAGEN
Today is Rare Disease Day! Take our quiz to expand your knowledge of rare diseases and contribute to NORD (National Organization for Rare Disorders) in the process. Be sure to #showyourstripes today!
-
QIAGEN
@QIAGEN
Rare Disease Day is tomorrow! Today's quiz question: how many rare disease have drug treatments? See if you know the answer and we'll donate to NORD (National Organization for Rare Disorders). #showyourstripes
-
QIAGEN
@QIAGEN
"For our lab, it was a transition that was necessary to provide answers to the first responders." – Michelle Volk, CEO and President, Great Lakes Lab #qiastatdx #syndromictesting
-
QIAGEN reposted
AdvaMed
@AdvaMedUpdate
#covid19 diagnostic testing will remain critical, as we continue to track and stop the spread + monitor vaccines’ efficacy against new mutations. Thierry Bernard, CEO of @QIAGEN shares more. www.abc15.com/rebound/coronavirus-investigations/despite-…
-
QIAGEN reposted
AdvaMed
@AdvaMedUpdate
“People are not going to just test for the flu; they will test for the flu and COVID at the same time.” Thierry Bernard, CEO of @QIAGEN discusses the future of #covid19 diagnostic testing. www.abc15.com/rebound/coronavirus-investigations/despite-…
-
QIAGEN reposted
QIAGEN Life Sciences
@QIAGENscience
Rare diseases are more common than you think. As we count down to #rarediseaseday on February 28, test your knowledge of rare diseases everyday with a new quiz question. For every submission and share, we'll donate to NORD (National Organization for Rare Disorders).
-
QIAGEN
@QIAGEN
It's day 3 of the #rarediseaseday countdown. How much do you know about rare disease? Try today's quiz question and we'll donate to NORD (National Organization for Rare Disorders). #showyourstripes
-
QIAGEN
@QIAGEN
Rare diseases are more common than you think. Count down to #rarediseaseday on Feb 28 by testing your knowledge with a new quiz question every day. For every submission, we'll donate to NORD (National Organization for Rare Disorders). #showyourstripes
-
QIAGEN
@QIAGEN
Testing for COVID will stay: “People are not going to just test for flu; they will test for flu and COVID at the same time.” – Thierry Bernard, CEO of QIAGEN www.abc15.com/rebound/coronavirus-investigations/despite-…
-
QIAGEN
@QIAGEN
📢 QIAGEN and INOVIO expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO’s VGX-3100 for advanced cervical dysplasia corporate.qiagen.com/newsroom/press-releases/2021/2021022…
-
QIAGEN
@QIAGEN
📢 Thomas Ebeling appointed to the Supervisory Board
-
QIAGEN
@QIAGEN
“We are proud to support passage of the Equality Act in the United States as this provides the LGBTQ+ community with consistent and clear protections against discrimination across key areas of life.” – Thierry Bernard, CEO of QIAGEN
Learn more: www.hrc.org -
QIAGEN reposted
QIAGEN Life Sciences
@QIAGENscience
Generate reliable DNA profiles fast in the most challenging conditions with the new #qiaamplifier 96. Simplicity, high performance and accurate temperature control meet all the #pcr needs of a busy #forensic lab. Download the flyer! ⬇️ #crimetocourt
-
QIAGEN
@QIAGEN
Every day, our #oncohematology solutions support advances in diagnosis, clinical #cancer research, and bioinformatics insights. Discover our real-world Blood Cancer Sample to Insight series today. #bloodcancertesting #ipsogen #leukemia #oncology #qiaseq
-
QIAGEN
@QIAGEN
QIAGEN announced strong results of operations for the fourth quarter and full-year 2020, exceeding the goals for net sales and adjusted earnings per share.
-
QIAGEN reposted
Biocompare
@biocompare
Do you want to know more about @QIAGEN 's RNAeasy Mini Kit? One of our product investigators recently reviewed it and said its "Recommend to anyone who wants a fast, reliable RNA isolation/purification." www.biocompare.com/Product-Reviews/572941-Good-RNAeasy-ki…
-
QIAGEN
@QIAGEN
“We estimate that RAID-CRC will eliminate the need for 32% of colonoscopies and detect 59% of pre-cancerous lesions.” – Dr. Mariona Serra, co-founder and CEO, GoodGut
Using bacterial signatures to screen for colorectal cancers:
www.qiagen.com/customer-stories/using-bacterial-signature… -
QIAGEN
@QIAGEN
Detecting cancer risks based on bacteria: “We estimate that RAID-CRC will eliminate the need for 32% of colonoscopies and detect 59% of pre-cancerous lesions.” – Dr. Mariona Serra, co-founder and CEO, GoodGut
-
QIAGEN
@QIAGEN
"I just kept thinking: What can we do? What can Great Lakes Labs do? We don't do clinical testing." – Michelle Volk, CEO and President of Great Lakes Labs #syndromictesting #qiastatdx www.qiagen.com/us/customer-stories/quick-pivot-enables-la…
-
QIAGEN
@QIAGEN
Accelerate detection of emerging SARS-CoV-2 variants such as B.1.1.7 and B.1.351 using a high-throughput whole viral genome sequencing workflow. Register for the Feb. 9 webinar for details ⬇️
-
QIAGEN
@QIAGEN
Just a few more days till the QIAGEN Virtual Symposium Reloaded. QIAGEN experts will be available for a live chat session at the exhibition booths, have you registered?
Feb 9 | 10 a.m. – 3 p.m. GMT+2 #qvsreloaded -
QIAGEN
@QIAGEN
Join our webinar on Feb. 9 to discover a scalable whole genome sequencing workflow that can accelerate genomic surveillance of new SARS-CoV-2 variants such as B.1.1.7 and B.1.351. Register now!
-
QIAGEN
@QIAGEN
Prepare for the new EU IVDR – the latest SPIDIA4P newsletter shows how! ➡️ www.spidia.eu/news-media/newsletter
Post not available here, view on X
QIAGEN
@QIAGEN
... by developing and implementing a portfolio of 22 pan-European CEN and international ISO standard documents, as well as external quality assessment schemes (EQAs), ultimately improving worldwide healthcare.
QIAGEN
@QIAGEN
Read about the latest updates and examples of successful implementation of CEN and ISO standards in the newly released SPIDIA4P newsletter ➡️ www.spidia.eu/news-media/newsletter
#spidia4p #personalizedmedicine -
QIAGEN reposted
Kelly Capper-Parkin
@kelly_beanzzz
I won a game from @QIAGEN. Luckily it can be played with 2 people so it's something we can play in lockdown!
-
QIAGEN
@QIAGEN
"Four years ago I was an intern at QIAGEN. I was lucky for getting the chance." - Nasim Jesri, Technical Assistant Assay Technologies
@stadthilden
Du-Ich-Wir e.V.
Rotary Club Hilden-Haan
#makingimprovementsinlifepossibleThis media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
📢 QIAGEN adds dPCR platform QIAcuity to growing portfolio of COVID-19 testing solutions for wastewater and mutation testing #dpcr #qiacuity
QIAGEN
@QIAGEN
• Digital PCR for COVID-19 wastewater testing overcomes limitations of traditional PCR
QIAGEN
@QIAGEN
• Wastewater surveillance testing can quantify COVID-19 in populations and track mutations
QIAGEN
@QIAGEN
• Custom QIAcuity One-Step Viral RT-PCR Kit supports wastewater testing applications
-
QIAGEN
@QIAGEN
Reducing obstacles to cervical cancer screening is crucial in the fight against #cervicalcancer. The ROSE foundation is an international collaboration that has dramatically increased cervical cancer screening rates in Malaysian women.
This media couldn't be displayed. See it on the original post.
QIAGEN
@QIAGEN
Share and support the Conquering Cancer Campaign: conqueringcancercampaign.com @ConqueringCancr @ProgramROSE
-
QIAGEN
@QIAGEN
Join us for a live Q&A session with experts on SARS-CoV-2 research and testing. Register for the virtual symposium and head to the exhibition hall on Feb 9 to chat with us. ➡️ qvs2020eu.vfairs.com
Feb 9 | 10 a.m. – 3 p.m. GMT+2 #qvsreloaded -
QIAGEN
@QIAGEN
Just a few more days till the QIAGEN Virtual Symposium Reloaded. QIAGEN experts will be available for a live chat session at the exhibition booths, have you registered? ➡️ qvs2020ap.vfairs.com
Feb 2 | 10 a.m. – 3 p.m. GMT+8 #qvsreloaded -
QIAGEN
@QIAGEN
Join @WHO @DrNonoSimelela for the #tealtalk Twitter Chat for #cervicalcancer Awareness Month on 19 January at 11 AM CET. Save the date to join us evt.mx/9fwHrhvy
-
QIAGEN
@QIAGEN
QIAGEN at Festival of Genomics 2021 #fog2021 online event. Register now ➡️ www.festivalofgenomics.com/register
-
QIAGEN
@QIAGEN
📢 QIAGEN confirms effectiveness of its SARS-CoV-2 PCR tests in the face of mutations of the coronavirus. Read press release ➡️ corporate.qiagen.com/newsroom/press-releases/2021/2021012…
Post not available here, view on X
QIAGEN
@QIAGEN
• QIAGEN started cross-checking variants in May 2020 and continues to conduct biweekly assessments
QIAGEN
@QIAGEN
• QIAseq SARS-CoV-2 Primer Panel helps with sequencing RNA and identifying mutations
-
QIAGEN
@QIAGEN
Join us for a live Q&A session with experts on SARS-CoV-2 research and testing. Register for the virtual symposium and head to the exhibition hall on Feb 2 to chat with us.
-
QIAGEN
@QIAGEN
How quickly is SARS-CoV-2 mutating?
Acquire phylogenetic insights and explore strain variation with our new NGS panel for targeted enrichment and sequencing of the complete SARS-CoV-2 genome. Request a trial kit ⬇️ -
QIAGEN
@QIAGEN
(1/5) Big news for the #lifescience community: Top geneticist Eric Lander has been chosen as presidential science adviser and director of the Office of Science and Technology Policy (OSTP).
Pic: Rick Friedmann for The New York Times www.nytimes.com/2012/01/03/science/broad-institute-direct…Post not available here, view on X
QIAGEN
@QIAGEN
(4/5) If the US Senate confirms Lander, he will serve as a member of the new Cabinet.
QIAGEN
@QIAGEN
(5/5) Eric Lander is the founding director of the Broad Institute of MIT and Harvard and was the lead author of the first paper announcing the details of the human genome.
-
QIAGEN
@QIAGEN
The emergence of new, highly transmissible SARS-CoV-2 variants is changing the trajectory of the pandemic. Whole viral genome sequencing using our NGS panel can reveal powerful insights.
-
QIAGEN
@QIAGEN
The value of molecular testing, stepping up to the challenge, launching new solutions and innovation: CEO Thierry Bernard on some of the big takeaways from 2020 and plans for 2021 #workthisway @NYSE
This media couldn't be displayed. See it on the original post. -
QIAGEN reposted
NYSE 🏛
@NYSE
Molecular testing company @Qiagen has been at the forefront of diagnostics during the pandemic. Learn about the key takeaways from CEO Thierry Bernard on #workthisway
This media couldn't be displayed. See it on the original post. -
Post not available here, view on X
QIAGEN
@QIAGEN
Check out the new publication highlighting the QIAprep& procedure as a paradigm shift in rapid molecular testing compared to standardized laboratory testing method: Journal of Clinical Virology - www.sciencedirect.com/science/article/pii/S13866532203046…
-
QIAGEN reposted
Wellcome Genome Campus
@wellcomegenome
A new partnership for @cosmic_sanger and @Qiagen to ensure longevity and development of a world-leading data resource for the #cancerresearch community
COSMIC Sanger
@cosmic_sanger
We are excited to announce our recent commercial distribution partnership with Qiagen GmbH. This enables us to protect the future of COSMIC, and continue sustaining and maintaining our valuable resource. Read more in our latest blog post
cosmic-blog.sanger.ac.uk/cosmic-announcement -
QIAGEN reposted
Maryland Commerce
@MDBiz
#icymi: @QIAGEN is expanding its United States Headquarters and research and development manufacturing facility in Montgomery County to accommodate for expanded production of testing products for COVID-19 and other diseases.
#mdbiohealth #open4bizmd
open.maryland.gov/blog/qiagen-continues-growth-maryland/ -
QIAGEN
@QIAGEN
Discover COVID-19 solutions and resources:
◾ Diagnostic testing
◾ Research solutions
◾ Latest news -
QIAGEN
@QIAGEN
📢 Dr. Toralf Haag appointed to Supervisory Board and a member of the Audit Committee. Read full PR: corporate.qiagen.com/newsroom/press-releases/2021/2021010…
-
QIAGEN
@QIAGEN
Most popular read in 2020: A story about digital PCR and obesity. #dpcr #qiacuity ➡️ www.qiagen.com/de-ch/customer-stories/identifying-the-gen…
-
QIAGEN
@QIAGEN
New dPCR techniques have been able to provide answers to why some people are susceptible to obesity in the oldest study of its kind.
⬇️This is our most popular customer story of 2020 ⬇️
#sampletoinsight #qiagenThis media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
2nd most popular story: Disrupting TB testing due to COVID will have major consequences worldwide. Dr. Alistair Story is putting TB back on the public’s radar as he continues to test London’s most vulnerable populations. www.qiagen.com/customer-stories/battling-tuberculosis-in-…
-
QIAGEN
@QIAGEN
Most popular read in 2020: A story about digital PCR and obesity. #dpcr #qiacuity ➡️ www.qiagen.com/de-ch/customer-stories/identifying-the-gen…
-
QIAGEN reposted
BBMRI-ERIC
@BBMRIERIC
3 more weeks to go!
Register www.bbmri-eric.eu/services/bbmri-qm-training-education/ now for our #bbmri_qm training and education programme on @isostandards for molecular in vitro diagnostic examination.
1st session is on Tue 6 October. Join Uwe Oelmueller VP Head of MDX Sample Technologies @Qiagen. #spidia4p -
QIAGEN
@QIAGEN
Dr. Alistair Story uses his 20 years of experience fighting the worlds oldest respiratory disease - TB - within London’s homeless population to provide strategies on controlling COVID-19.
2nd most popular customer story 2020. For more, visit qiagen.com/customer-storiesThis media couldn't be displayed. See it on the original post. -
QIAGEN reposted
IRD Global
@IRDGlobal
When his uncle was diagnosed with TB disease, all Shoaib & his family felt was fear. Through IRD's study in partnership with IHN, & the QIAreach QFT test, Shoaib was able to have his whole family tested for TB infection immediately. @QIAGEN @indus_hospital
fb.watch/2pLaBK2NC-/ -
QIAGEN
@QIAGEN
3rd most popular story this year is about scientists researching all aspects of #climatechange: Read how Dr. Darren Chooneea scrutinizes the #molecular details of air to gain valuable insights.
-
QIAGEN
@QIAGEN
Testing air samples can warn researchers about threats to crops, changes in biodiversity and even the evolution of climate change.
Find out how Dr. Chooneea finds unique insights form this invisible ecosystem.
#sampletoinsight #qiagenThis media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
4th most popular read on qiagen.com/customer-stories: Molecular biologists support the fight against illegal wildlife trade – find out how they help guide law enforcement ⬇️
-
QIAGEN
@QIAGEN
Illegal wildlife is a rampant problem in the Philippines. Watch the story behind the 4th most popular article 2020: Saving biodiversity through DNA barcoding #sampletoinsight
This media couldn't be displayed. See it on the original post. -
QIAGEN
@QIAGEN
📢 QIAGEN announced today that it has raised its full-year 2020 outlook for growth of net sales and adjusted earnings per share (EPS) and is looking forward to another strong performance in 2021. Read the release: corporate.qiagen.com/newsroom/press-releases/2020/2020120…
-
QIAGEN
@QIAGEN
5th most popular story on qiagen.com: Find out how one diagnostic lab is handling over 1000 SARS-CoV-2 samples each day in addition to their usual workload:
-
QIAGEN
@QIAGEN
📢 QIAGEN to launch QuantiFERON SARS-CoV-2 for research into causes, spread and control of #covid19 through T-cell response. Read the release: corporate.qiagen.com/newsroom/press-releases/2020/2020120…
QIAGEN
@QIAGEN
• T-cell response has the potential to give a clearer picture of immunity and course of illness
• T-cell response to SARS-CoV-2 may decline less rapidly than antibodies
• Potentially vital tool for research into immune response and vaccination efficacy -
QIAGEN
@QIAGEN
Statista and 𝘴𝘵𝘦𝘳𝘯 magazine have confirmed QIAGEN to be one of the most sustainable companies in Germany.
We made it into the top 10% of 2000 companies assessed. This recognition fuels our ambition to lead our industry and reduce environmental footprints.
QIAGEN
@QIAGEN
Learn more about QIAGEN´s sustainability efforts: www.qiagen.com/sustainability
More information about the ranking: www.stern.de/esg (German only)
Let´s keep moving and #makingimprovementsinlifepossible -
QIAGEN
@QIAGEN
Treatments for patients on day one: A novel #cancer treatment gets approval. How can the companion diagnostics be ready on that day, too? Get the story: www.qiagen.com/de-ch/customer-stories/treatments-for-pati…
-
QIAGEN
@QIAGEN
“We are now applying these methods to explore the international standardization of COVID-19 testing. Once again, we have been impressed with the results.” – Dr. Jim Huggett, Principal Scientist, National Measurement Laboratory
-
QIAGEN
@QIAGEN
“This strategic step with Thermo Fisher will enable us to enter a promising new era and will give our employees the opportunity to have an even greater impact." - Thierry Bernard, interim CEO of QIAGEN N.V. and SVP, head of the molecular diagnostics business area
-
QIAGEN
@QIAGEN
Another late night in the lab? Here’s an idea to keep you going tonight and every night. Take an upgrade…



































































































































































